<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47566</article-id><article-id pub-id-type="doi">10.7554/eLife.47566</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>The adhesion-GPCR BAI1 shapes dendritic arbors via Bcr-mediated RhoA activation causing late growth arrest</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-137750"><name><surname>Duman</surname><given-names>Joseph G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6711-0656</contrib-id><email>duman@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-138211"><name><surname>Mulherkar</surname><given-names>Shalaka</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8736-527X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-138212"><name><surname>Tu</surname><given-names>Yen-Kuei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-138213"><name><surname>Erikson</surname><given-names>Kelly C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-142016"><name><surname>Tzeng</surname><given-names>Christopher P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-138215"><name><surname>Mavratsas</surname><given-names>Vasilis C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-138216"><name><surname>Ho</surname><given-names>Tammy Szu-Yu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa3">§</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-36634"><name><surname>Tolias</surname><given-names>Kimberley F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2092-920X</contrib-id><email>tolias@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Neuroscience</institution><institution>Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Graduate Program in Integrative Molecular and Biomedical Sciences</institution><institution>Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Rice University</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Program in Developmental Biology</institution><institution>Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Verna and Marrs McLean Department of Biochemistry and Molecular Biology</institution><institution>Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>West</surname><given-names>Anne E</given-names></name><role>Reviewing Editor</role><aff><institution>Duke University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Biology, Stanford University, Stanford, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>School of Medicine, University of Texas Medical Branch, Galveston, United States</p></fn><fn fn-type="present-address" id="pa3"><label>§</label><p>Departments of Neurology and Neurobiology, Harvard Medical School, Boston Children’s Hospital, Boston, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>28</day><month>08</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e47566</elocation-id><history><date date-type="received" iso-8601-date="2019-04-09"><day>09</day><month>04</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-08-03"><day>03</day><month>08</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Duman et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Duman et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47566-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.47566.001</object-id><p>Dendritic arbor architecture profoundly impacts neuronal connectivity and function, and aberrant dendritic morphology characterizes neuropsychiatric disorders. Here, we identify the adhesion-GPCR BAI1 as an important regulator of dendritic arborization. BAI1 loss from mouse or rat hippocampal neurons causes dendritic hypertrophy, whereas BAI1 overexpression precipitates dendrite retraction. These defects specifically manifest as dendrites transition from growth to stability. BAI1-mediated growth arrest is independent of its Rac1-dependent synaptogenic function. Instead, BAI1 couples to the small GTPase RhoA, driving late RhoA activation in dendrites coincident with growth arrest. BAI1 loss lowers RhoA activation and uncouples it from dendrite dynamics, causing overgrowth. None of BAI1’s known downstream effectors mediates BAI1-dependent growth arrest. Rather, BAI1 associates with the Rho-GTPase regulatory protein Bcr late in development and stimulates its cryptic RhoA-GEF activity, which functions together with its Rac1-GAP activity to terminate arborization. Our results reveal a late-acting signaling pathway mediating a key transition in dendrite development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>branching</kwd><kwd>retraction</kwd><kwd>hippocampal cultures</kwd><kwd>Raichu</kwd><kwd>Long-Evans rats</kwd><kwd>RhoA-FLARE</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS062829</award-id><principal-award-recipient><name><surname>Tolias</surname><given-names>Kimberley F</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01MH109511</award-id><principal-award-recipient><name><surname>Tolias</surname><given-names>Kimberley F</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>K01MH089112</award-id><principal-award-recipient><name><surname>Duman</surname><given-names>Joseph G</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Mission Connect-TIRR Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Tolias</surname><given-names>Kimberley F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The adhesion-GPCR BAI1 shapes dendritic arbors in the hippocampus by associating with Bcr late in development and stimulating its RhoA-GEF activity, resulting in dendritic growth arrest.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>A dizzying array of dendritic arbors receives and processes information transiting the brain (<xref ref-type="bibr" rid="bib25">Harris and Spacek, 2016</xref>; <xref ref-type="bibr" rid="bib50">Landgraf and Evers, 2005</xref>; <xref ref-type="bibr" rid="bib54">Lefebvre et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Polavaram et al., 2014</xref>). Arbor morphology controls neuronal availability to inputs (<xref ref-type="bibr" rid="bib50">Landgraf and Evers, 2005</xref>; <xref ref-type="bibr" rid="bib54">Lefebvre et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Häusser and Mel, 2003</xref>) and contributes to input processing (<xref ref-type="bibr" rid="bib26">Häusser and Mel, 2003</xref>; <xref ref-type="bibr" rid="bib23">Grienberger et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Henze et al., 1996</xref>; <xref ref-type="bibr" rid="bib59">London and Häusser, 2005</xref>). Thus, arbor malformation or degradation manifests in numerous neurodevelopmental and neurodegenerative diseases (<xref ref-type="bibr" rid="bib44">Kulkarni and Firestein, 2012</xref>). Due to the plethora of dendritic arbor morphologies, many of which are highly elaborate, arbor construction represents a significant cell biological challenge. Intrinsic genetic programs are important, but insufficient, for instructing neurons to form correct dendrite architecture, and extrinsic signals and signaling pathways must supply critical environmental information (<xref ref-type="bibr" rid="bib54">Lefebvre et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Dong et al., 2015</xref>).</p><p>Final arbor structure arises from a tension between drivers and restrictors of dendritic growth (<xref ref-type="bibr" rid="bib54">Lefebvre et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Dong et al., 2015</xref>). Restrictor failure leads to dendritic overgrowth, while ectopic restrictor activation causes dendrite retraction. Many studies have shown alterations in brain size (both macro- and microcephaly) in patients with autism spectrum disorder (ASD), particularly affecting the hippocampus, which functions in spatial learning, memory consolidation, and emotional control (<xref ref-type="bibr" rid="bib44">Kulkarni and Firestein, 2012</xref>; <xref ref-type="bibr" rid="bib7">Copf, 2016</xref>; <xref ref-type="bibr" rid="bib20">Fombonne et al., 1999</xref>; <xref ref-type="bibr" rid="bib49">Lainhart et al., 1997</xref>). Dendrites account for at least 30–40% of gray matter volume (<xref ref-type="bibr" rid="bib8">Curran et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Karbowski, 2015</xref>; <xref ref-type="bibr" rid="bib34">Kasthuri et al., 2015</xref>), so defects in arbor size could contribute to such brain defects. Indeed, dendritic hypertrophy is observed in the hippocampi of mouse models of ASD (<xref ref-type="bibr" rid="bib6">Cheng et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Kwon et al., 2006</xref>), and dendritic hypotrophy characterizes other forms of ASD (<xref ref-type="bibr" rid="bib44">Kulkarni and Firestein, 2012</xref>; <xref ref-type="bibr" rid="bib45">Kweon et al., 2017</xref>). Further, humans and mice suffering from chronic stress, depression/depressive-like behavior, or neurodegenerative disease exhibit dendritic hypotrophy (<xref ref-type="bibr" rid="bib44">Kulkarni and Firestein, 2012</xref>; <xref ref-type="bibr" rid="bib12">de Flores et al., 2015</xref>; <xref ref-type="bibr" rid="bib106">Zhao et al., 2017</xref>).</p><p>ASD-associated macrocephaly manifests well after birth (<xref ref-type="bibr" rid="bib49">Lainhart et al., 1997</xref>; <xref ref-type="bibr" rid="bib90">Stigler et al., 2011</xref>), which implicates the dysfunction of late-acting dendrite restriction mechanisms. While recent work has begun to illuminate the molecular nature of the stable state of dendrites subsequent to growth (<xref ref-type="bibr" rid="bib36">Kerrisk et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">Lin et al., 2013</xref>), little is known about the events whereby neurons in the hippocampus make this transition. The small GTPase Rem2 (<xref ref-type="bibr" rid="bib22">Ghiretti et al., 2013</xref>), the leucine-rich repeat protein Lrig1 (<xref ref-type="bibr" rid="bib2">Alsina et al., 2016</xref>), and the adhesion-GPCR (A-GPCR) CELSR3 (<xref ref-type="bibr" rid="bib83">Shima et al., 2007</xref>) all contribute to apparently separate pathways that act as a brake on hippocampal dendrite growth in response to various stimuli during early postnatal development, but almost nothing is known about how these neurons transition out of a net growth state to the more mature, stable state.</p><p>Brain-specific angiogenesis inhibitor 1 (BAI1, also ADGRB1(28)) is an A-GPCR that instigates phagocytosis of apoptotic cells and Gram-negative bacteria (<xref ref-type="bibr" rid="bib10">Das et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Elliott et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>). BAI1 is expressed in the cortex, hippocampus, striatum, and thalamus in neurons and glia (<xref ref-type="bibr" rid="bib87">Sokolowski et al., 2011</xref>) and suppresses brain angiogenesis (<xref ref-type="bibr" rid="bib35">Kaur et al., 2005</xref>), its loss promoting glioblastoma (<xref ref-type="bibr" rid="bib38">Koh et al., 2004</xref>; <xref ref-type="bibr" rid="bib107">Zhu et al., 2011</xref>). BAI1 also regulates dendritic spine formation, excitatory synaptogenesis and synaptic plasticity in the hippocampus and cortex (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). We demonstrated that BAI1 promotes spino- and synaptogenesis by recruiting the Par3/Tiam1 polarity complex to spines, resulting in localized activation of the small GTPase Rac1 and actin cytoskeletal remodeling (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). Moreover, we recently reported that BAI1 functionally interacts with the ASD-associated synaptic organizer Neuroligin-1, and coordinates trans-synaptic signaling important for excitatory synaptogenesis (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). Notably, the BAI1 gene is located in a hot spot for de novo germline mutations in human ASD patients (<xref ref-type="bibr" rid="bib60">Michaelson et al., 2012</xref>), and BAI1 SNPs associate with educational attainment and mathematical ability (<xref ref-type="bibr" rid="bib53">Lee et al., 2018</xref>). Moreover, BAI1 mRNA is elevated in mouse models of Rett and MeCP2 duplication syndromes, both of which exhibit altered dendritic arbors and ASD-like symptoms (<xref ref-type="bibr" rid="bib4">Chahrour et al., 2008</xref>; <xref ref-type="bibr" rid="bib100">Urdinguio et al., 2008</xref>).</p><p>We report here that BAI1 also functions to restrict the growth of dendritic arbors in hippocampal pyramidal cells. This restriction happens late in development as dendritic arbors transition from growth to stabilization. While no known modes of BAI1 signaling account for its ability to restrict dendritic growth, we show that it activates the small GTPase RhoA by stimulating the cryptic RhoA-guanine nucleotide exchange factor (GEF) activity of the breakpoint cluster region protein (Bcr), and that Bcr’s activation of RhoA is required in concert with its inhibition of the small GTPase Rac1 to mediate growth arrest. This previously unidentified pathway represents a potential clinical target for diseases that alter dendritic arbor form.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>BAI1 loss results in late developmental dendritic overgrowth</title><p>We have shown that BAI1 promotes spinogenesis and excitatory synaptogenesis in cultured hippocampal neurons and in vivo in mouse cortex and hippocampus (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). To determine the contribution of BAI1 to dendritic arbor development, we introduced an shRNA against <italic>Adgrb1</italic> (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and enhanced green fluorescent protein (EGFP) into embryonic day 14 (E14) mice via in utero electroporation and assayed the effects at postnatal day 21 (P21). The shRNA lowered BAI1 expression in neuronal somata to undetectable levels, but spared non-transfected cells (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Use of shRNA to lower BAI1 levels is hereafter referred to as BAI1 Kd. The dorsolateral hippocampal CA1 region exhibited a striking increase in dendrite density in BAI1 knockdown (Kd) brains relative to controls, though transfection levels were similar (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). We reconstructed the dendritic arbors of neurons whose somata resided in the center of 100 µm slices cut from control (<xref ref-type="fig" rid="fig1">Figure 1c</xref>) and BAI1 Kd (<xref ref-type="fig" rid="fig1">Figure 1d</xref>) brains, revealing that BAI1 Kd resulted in longer arbors (<xref ref-type="fig" rid="fig1">Figure 1e</xref>), increased dendrite number (<xref ref-type="fig" rid="fig1">Figure 1f</xref>), and increased branch points (<xref ref-type="fig" rid="fig1">Figure 1g</xref>) relative to controls. Though BAI1 Kd arbors overgrew, they showed no excess dorsoventral penetration (<xref ref-type="fig" rid="fig1">Figure 1h</xref>), indicating that they were still subject to hippocampal boundaries. BAI1 Kd arbors were also wider than those of control neurons (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a,b</xref>). The effects of BAI1 Kd were apparent in both apical and basal dendrites (<xref ref-type="fig" rid="fig1">Figure 1e–g</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a,b</xref>), though apical dendrites showed greater sensitivity to BAI1 loss (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2c</xref>). We also observed defects in the orientation of primary apical dendrites from BAI1 Kd neurons (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2d,e</xref>). Thus, sparse in vivo loss of BAI1 expression causes striking mis- and overgrowth of hippocampal pyramidal neuron dendritic arbors.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.002</object-id><label>Figure 1.</label><caption><title>BAI1 restricts dendrite growth in the developing hippocampus and hippocampal cultures.</title><p>(<bold>a</bold>) Representative in vivo images showing optical sections through the centers of neuronal somata from mice transfected with EGFP and shRNA against <italic>Adgrb1</italic> and stained for BAI1. Note that the transfected neuron expressing EGFP and shRNA has substantially lower BAI1 staining that the neighboring untransfected neuron, indicating successful BAI1 knockdown. (<bold>b</bold>) 100 µm thick slices of dorsolateral CA1 from mice transfected with EGFP (Control) or EGFP and shRNA against BAI1 (BAI1 Kd). Bar is 50 µm. c and d Reconstructions of representative control (<bold>c</bold>) and BAI1 Kd (<bold>d</bold>) dendritic arbors from slices like those in b. (<bold>e</bold>) Summary data for dendrite length. (<bold>f</bold>) Summary data for dendrite number. (<bold>g</bold>) Summary data for branch points. (<bold>h</bold>) Summary data for dendrite penetration. Total number of neurons: 21 (N = 3) for control and 41 (N = 4) for BAI1 Kd. (<bold>i</bold>) Representative images of neurons expressing EGFP alone (control) or with shRNA against <italic>Adgrb1</italic> (BAI1 Kd) or with shRNA against BAI1 and RNAi-resistant BAI1 (Rescue). Images are masked to remove axons and dendrites from other neurons. Bar is 20 µm. (<bold>j</bold>) Summary data for total length of cultured neurons. (<bold>k</bold>) Summary data for total dendrite number in cultured neurons. Total number of neurons in j and k: 118 for control neurons, 106 for BAI1 Kd neurons, and 65 for rescue neurons (N = 7). Data are represented as mean ± s.e.m. (***p&lt;0.001) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p><supplementary-material id="fig1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.010</object-id><label>Figure 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig1">Figure 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig1">Figure 1e–h,j–k</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.007</object-id><label>Figure 1—source data 2.</label><caption><title>Individual values for in vivo and cultured neurons demonstrating the effects of BAI1 loss on arbor growth (<xref ref-type="fig" rid="fig1">Figure 1e–h,j–k</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.008</object-id><label>Figure 1—source data 3.</label><caption><title>Quantification of Western bands showing expression levels of BAI1, BAI2, and BAI3 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><object-id pub-id-type="doi">10.7554/eLife.47566.009</object-id><label>Figure 1—source data 4.</label><caption><title>Extended individual values for in vivo and cultured neurons showing the effects of BAI1 loss on arbor growth (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a,b,e,g,h,i,j</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>shRNA-mediated BAI1 Kd and effects on other BAIs.</title><p>(<bold>a</bold>) Schematic representation of <italic>Adgrb1</italic> mRNA showing the sites targeted by shRNA1 (blue) and shRNA2 (red). (<bold>b</bold>) Results of rtPCR of the indicated targets on RNA isolated from 16 DIV hippocampal neurons to which EGFP and pSuper, shRNA1, or shRNA2 had been introduced on DIV three via calcium chloride transfection. Based on EGFP expression, we estimate that 40–50% of the neurons were transfected. (<bold>c</bold>) Representative Western blots of the indicated proteins in post-nuclear supernatants of hippocampal neurons like those used for RNA isolation in panel b. (<bold>d</bold>) Quantification of BAI1-3 band density from repeats of the experiments shown in panel c. Black bars indicate pSuper-expressing samples, blue indicates shRNA1-expressing samples, and red indicates shRNA2-expressing samples. *p&lt;0.05; **p&lt;0.01, N = 4. (<bold>e</bold>) Serial dilutions of pSuper- and shRNA1-expressing samples indicate a linear relationship between band intensity and protein levels. These samples also show actin as a loading control. Taken together with the immunofluorescence data in <xref ref-type="fig" rid="fig1">Figure 1a</xref>, <xref ref-type="fig" rid="fig5">Figure 5a–e</xref>, and (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>), these data indicate a strong knockdown of BAI1 in transfected neurons. Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig1s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.004</object-id><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>BAI1 restricts dendrite growth in developing hippocampus.</title><p>(<bold>a</bold>) Summary data of the maximal lateral width of dendritic arbors. (<bold>b</bold>) Summary data of minimum angle centered on the cell body that includes the entire indicated dendritic domain. (<bold>c</bold>) % change in each of the indicated parameters for apical and basal dendrites. Note that the apical dendrites are more affected than basal dendrites by BAI1 Kd. (<bold>d</bold>) Representative images of neurons aligned so that the hippocampal cell layer was parallel to the page. (<bold>e</bold>) Summary data of the position of the primary apical dendrite. Total number of neurons: 19 for control neurons (N = 3) and 38 for BAI1 Kd neurons (N = 4). (<bold>f</bold>) Representative images of hippocampal neurons expressing EGFP and empty vectors (control), shRNA against <italic>Adgrb1</italic> (BAI1 Kd) or shRNA against BAI1 and RNAi-resistant BAI1 (Rescue) fixed at 21 DIV. Images are masked to remove all axons and dendrites from other neurons. (<bold>g</bold>) Summary data for dendrite length. (<bold>h</bold>) Summary data for dendrite number. (<bold>i</bold>) Summary data for Sholl crossings with shRNA1. (<bold>j</bold>) Summary data for Sholl crossings with shRNA2. Total number of neurons for shRNA1 experiments: 118 for control neurons, 106 for BAI1 Kd neurons, and 65 for rescue neurons (N = 7). Total number of neurons for shRNA2 experiments: 39 for control neurons, 34 for BAI1 Kd neurons, and 35 rescue neurons (N = 4). Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig1s2sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.006</object-id><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a,b,e,g–j</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig1-figsupp2-v1.tif"/></fig></fig-group><p>We tested whether dendritic overgrowth also manifests in primary hippocampal cultures. <xref ref-type="fig" rid="fig1">Figure 1i</xref> shows the somatodendritic domains of representative cultured neurons from control, BAI1 Kd, and BAI1 Kd neurons expressing RNAi-resistant wild-type BAI1 (Rescue). The effects of BAI1 Kd on arbor length (<xref ref-type="fig" rid="fig1">Figure 1j</xref>), dendrite number (<xref ref-type="fig" rid="fig1">Figure 1k</xref>), and dendritic arbor complexity (as measured by Sholl analysis, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2i</xref>) revealed that BAI1 Kd also caused dendrite overgrowth in neuronal cultures and that this was rescued by reintroduction of BAI1. Arbor overgrowth was also apparent when a separate, non-overlapping shRNA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) directed against BAI1 was introduced into cultured neurons, and these defects were also rescued by RNAi-resistant wild type BAI1 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2f–h,j</xref>). Thus, BAI1 Kd with either of two shRNAs in cultured hippocampal neurons reproduced the in vivo effects of BAI1 Kd.</p><p>To gain insight into BAI1-mediated dendritic arbor restriction, we determined the time courses of BAI1 Kd and arbor growth. Initially, shRNAs were introduced into hippocampal neurons at 7 days in vitro (DIV), and neurons were fixed and stained at various times. Some loss of BAI1 was apparent in BAI1 Kd neurons by 10 DIV, becoming complete at 14 DIV and persisting though at least 21 DIV (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>). Significant arbor growth occurred in all neurons between 10 and 17 DIV; however, control neurons stopped growing at 17 DIV, while BAI1 Kd neurons continued to grow through at least 21 DIV (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b,c</xref>). We also performed longitudinal imaging of neurons into which shRNA was introduced at 6 DIV and obtained similar results. At 10 DIV, BAI1 Kd neurons had fewer and shorter dendrites than controls, but they surpassed control neurons in dendrite tip number by DIV 14 and in length by 17 DIV (<xref ref-type="fig" rid="fig2">Figure 2a–c</xref>). The longitudinal nature of these experiments allowed measurement of branch dynamics. Branch formations and eliminations decreased over the 10–22 DIV time course in control and BAI1 Kd neurons, but more slowly in BAI1 Kd neurons (<xref ref-type="fig" rid="fig2">Figure 2a,d,e</xref>). These data show that BAI1 loss removes a late-acting brake on arbor development, leading to longer, more branched, and less stable dendritic arbors.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.011</object-id><label>Figure 2.</label><caption><title>BAI1 exercises its effects on dendritic growth arrest late in development.</title><p>(<bold>a</bold>) Representative longitudinal series from neurons transfected on 6 DIV with EGFP (Control) or EGFP and shRNA against <italic>Adgrb1</italic> (BAI1 Kd) imaged at the indicated times. Images are masked to remove axons and dendrites from other neurons. Bar is 10 µm. (<bold>b</bold>) Summary data of total dendrite length. (<bold>c</bold>) Summary data of total dendrite number. (<bold>d</bold>) Summary data of branch formations. (<bold>e</bold>) Summary data of branch eliminations. Total number of neurons represented in panels <bold>a–e</bold>): 61 for control neurons and 22 for BAI1 Kd neurons (N = 5). Data are represented as mean ± s.e.m. with mathematical fits. (<bold>f</bold>) Representative longitudinal images of neurons expressing EGFP alone (Control) or with overexpression of <italic>Adgrb1</italic> (BAI1 OX). Neurons were fixed on 21 DIV and immunostained for BAI1. White arrows in the 17 DIV panels indicate dendrites eliminated by 21 DIV, while yellow arrowheads in 21 DIV panels indicate dendrites formed since 17 DIV. Images are masked to remove axons and dendrites from other neurons. Bar is 10 µm. (<bold>g</bold>) Summary data for dendrite length. (<bold>h</bold>) Summary data for dendrite number. (<bold>i</bold>) Summary data for branch number. (<bold>j</bold>) Summary data for integrated Sholl crossings. (<bold>k</bold>) Summary data for primary dendrites. (<bold>l</bold>) Summary data for dendrite dynamics. Total number of neurons represented in panels (<bold>f–l</bold>): 105 neurons (N = 3). Symbols positioned between points indicate differences between populations at the different time points. Data are represented as mean ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.016</object-id><label>Figure 2—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig2">Figure 2</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig2">Figure 2c–e,g–l</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.014</object-id><label>Figure 2—source data 2.</label><caption><title>Individual values for BAI1 Kd and OX time course experiments (<xref ref-type="fig" rid="fig2">Figure 2b–e,g–l</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig2-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.015</object-id><label>Figure 2—source data 3.</label><caption><title>Individual values for arbor growth in fixed time courses and BAI1 subcellular staining levels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1c,h</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig2-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.012</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Manipulation of BAI1 leads to altered dendrite growth in fixed populations of neurons; BAI1 localizes to dendritic tips later in development.</title><p>(<bold>a</bold>) Representative images of hippocampal neuronal somata from control and BAI1 Kd neurons fixed at the indicated times and stained for BAI1. Bar is 5 µm. (<bold>b</bold>) Representative somatodendritic domains from EGFP-expressing hippocampal neurons from control conditions or neurons transfected with either of the shRNAs against BAI1 from <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> on 7 DIV and fixed at the indicated times. Images are masked to remove axons and dendrites from other neurons. Bar is 10 µm. (<bold>c</bold>) Summary data of dendrite length. Total number of neurons: 40 for all conditions on 10 DIV; 48, 50, and 46 neurons for vector, shRNA1, and shRNA2 on 14 DIV; 28, 26, 24 for these conditions on 17 DIV; and 79, 61, and 26 for these conditions on 21 DIV (N = 4). (<bold>d</bold> and <bold>e</bold>) Representative images of EGFP, immunostaining of endogenous BAI1, and colocalization of these two. Shown are regions of branch points between primary and secondary dendrites (<bold>d</bold>) and dendrite tips (<bold>e</bold>). White arrowheads show the location of tips on the BAI1 channel, while black arrowheads show the branch points. Images are masked to remove axons and dendrites from other neurons. Bar is 5 µm. (<bold>h</bold>) BAI1 levels at dendrite tips and branch points were quantified relative to average neuronal BAI1 staining (assigned a value of 1.0) at the indicated times. Total number of neurons is the same as reported in panel c. Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig2s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.013</object-id><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1 c, f</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We previously demonstrated that BAI1 is enriched in hippocampal dendritic spines (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). To determine BAI1 expression in other loci germane to dendrite development, we examined BAI1-staining in the neurons used in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a–c</xref>. We were especially interested in dendrite tips and branch points, which contribute to dendrite growth dynamics (<xref ref-type="bibr" rid="bib13">Dong et al., 2015</xref>). BAI1 was present at branch points at 14, 17, and 21 DIV, but did not vary relative to total dendritic BAI1 staining over this time course (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1d–f</xref>). This differed strikingly from the behavior of BAI1 at dendritic tips. 14 DIV neurons exhibited little BAI1 staining at the dendritic tips, but clear BAI1 staining appeared by 17 DIV and persisted through at least 21 DIV (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1d–f</xref>). Thus, BAI1 is present throughout dendrites and critical growth loci at the time of dendrite growth arrest.</p><p>Our results demonstrate that BAI1 loss leads to late dendritic arbor overgrowth. However, is the converse true, i.e. does late BAI1 overexpression (OX) cause arbor retraction? To test this, we overexpressed BAI1 in cultured neurons at 6 DIV and took longitudinal images at 17 and 21 DIV. BAI1 OX was distributed throughout the somatodendritic domains of transfected neurons (<xref ref-type="fig" rid="fig2">Figure 2f</xref>). BAI1 OX and control neurons exhibited similar length, dendrite and branch number, and integrated Sholl crossings at 17 DIV, and these parameters remained fairly constant at 21 DIV in control neurons (<xref ref-type="fig" rid="fig2">Figure 2f–j</xref>). In contrast, all of these parameters had decreased by 21 DIV in BAI1 OX neurons (<xref ref-type="fig" rid="fig2">Figure 2f–j</xref>). Additionally, BAI1 OX neurons exhibited one more primary dendrite than control neurons at 17 DIV that disappeared by 21 DIV (<xref ref-type="fig" rid="fig2">Figure 2f,k</xref>). In agreement with the data in <xref ref-type="fig" rid="fig2">Figure 2d–e</xref>, branch formation and elimination was essentially balanced in control neurons from 17 to 21 DIV, whereas BAI1 OX decreased branch formation and increased branch elimination (<xref ref-type="fig" rid="fig2">Figure 2f,l</xref>). Taken together, <xref ref-type="fig" rid="fig1">Figures 1</xref>–<xref ref-type="fig" rid="fig2">2</xref> suggest that BAI1 mediates the transition from arbor growth to termination and arbor stabilization.</p></sec><sec id="s2-2"><title>BAI1 connects RhoA to normal dendritic growth arrest</title><p>How does BAI1 cause dendritic arbor growth arrest? One obvious candidate mechanism is via inhibition of the small GTPase Rac1, which promotes dendrite growth and branching (<xref ref-type="bibr" rid="bib13">Dong et al., 2015</xref>; <xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>; <xref ref-type="bibr" rid="bib18">Evers et al., 2000</xref>; <xref ref-type="bibr" rid="bib57">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib86">Sin et al., 2002</xref>; <xref ref-type="bibr" rid="bib103">Wong et al., 2000</xref>). We investigated this possibility by measuring long-term Rac1 activation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) in control and BAI1 Kd neurons with a Raichu-Rac1 FRET probe (<xref ref-type="bibr" rid="bib39">Komatsu et al., 2011</xref>), but determined that this was probably not the case, as differences in Rac1 activation in BAI1 Kd neurons were not those expected to drive dendrite growth (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2a–c</xref>). Another potential mechanism of BAI1-mediated growth arrest is activation of the small GTPase RhoA, which inhibits dendrite arbor elaboration (<xref ref-type="bibr" rid="bib75">Redmond and Ghosh, 2001</xref>). We therefore used the Raichu-RhoA FRET probe (<xref ref-type="bibr" rid="bib66">Nakamura et al., 2006</xref>) to measure RhoA activation in control and BAI1 Kd neurons (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Strikingly, control neurons exhibited a marked increase in RhoA activation at dendrite tips (<xref ref-type="fig" rid="fig3">Figure 3a,b</xref>) and branch points (<xref ref-type="fig" rid="fig3">Figure 3a,c</xref>) late in development. BAI1 Kd neurons, by contrast, showed blunted and delayed RhoA activation at the end of the 15–23 DIV developmental window (<xref ref-type="fig" rid="fig3">Figure 3a–c</xref>). These data reveal that BAI1 mediates a heretofore-undescribed late RhoA activation accompanying dendritic growth arrest.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.017</object-id><label>Figure 3.</label><caption><title>BAI1 drives a late dendritic RhoA activation peak and ties RhoA activation to dendrite behavior.</title><p>(<bold>a</bold>) Representative images of hippocampal neurons expressing Raichu-RhoA alone (control) or with shRNAs against <italic>Adgrb1</italic> (BAI1 Kd) measured at the indicated times. Overall dendrite structure was ascertained by directly exciting the FRET acceptor (YFP images), while relative RhoA activation is shown in the FRET images according to the color code in the lower right corner (low values on the left, high on the right). Images are masked to remove axons and dendrites from other neurons. Bar is 20 µm. (<bold>b</bold>) Summary data of RhoA activation at dendrite tips. (<bold>c</bold>) Summary data of RhoA activation at dendrite branch points. Total number of neurons: 49 (15 DIV, control), 27 (15 DIV, BAI1 Kd), 34 (17 DIV, control), 20 (17 DIV, BAI1 Kd), 35 (18 DIV, control), 34 (18 DIV, BAI1 Kd), 36 (20 DIV, control), 38 (20 DIV, BAI1 Kd), 37 (21 DIV, control), 32 (21 DIV, BAI1 Kd), 53 (23 DIV, control), and 31 (23 DIV, BAI1 Kd) (N = 5). (<bold>d</bold>) Pie charts showing the behavior of hippocampal dendrites persistent from 16 to 21 DIV in Control and BAI1 Kd neurons. Throughout this figure, stable dendrites are shown in black, retracting dendrites in red, and extending dendrites in blue. e and f Representative longitudinal images of extending (left) and retracting (right) dendrites in Control (<bold>e</bold>) and BAI1 Kd (<bold>f</bold>) neurons expressing the RhoA-FLARE reporter. The color scale for RhoA activation is the same as in panel A. Arrows track dendrite tip location. Images are masked to remove axons and dendrites from other neurons. Bar is 10 µm. (<bold>g</bold>) Summary of RhoA activation levels at dendrite tips in control (left) and BAI1 Kd (right) neurons through time. RhoA activation levels in stable neurons were also stable and assigned a value of 0 throughout the time course. All data were scaled to the average value of FRET in control somata on 16 DIV for the appropriate repeat of the experiment. (<bold>h</bold>) Same as panel g, but for dendrite branch points. (<bold>i</bold>) RhoA activation levels from all dendrites (stable, retracting, and extending) were pooled and plotted against day-long changes in dendritic length in control (black) and BAI1 Kd (green) neurons and linear fits were applied as shown. The inset to this panel shows the slopes extracted from these linear fits. Total number of dendrites represented in panels e-h, 922 for control (from 50 neurons) and 821 for BAI1 Kd (from 38 neurons) (N = 5). Data are represented as mean ± s.e.m., except for the inset to panel i, which is shown ± 95% confidence intervals. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05; §p&lt;1<sc>e</sc>-6 vs. control retracting) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.028</object-id><label>Figure 3—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig3">Figure 3</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig3">Figure 3b,c,g,h</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.024</object-id><label>Figure 3—source data 2.</label><caption><title>Individual values for RhoA activation and related values over fixed and longitudinal time courses (<xref ref-type="fig" rid="fig3">Figure 3b,c,g–i</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.025</object-id><label>Figure 3—source data 3.</label><caption><title>Individual measurements for long-term Rho-GTPase measurements in Cos-7 cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b,d,f,h,j,k</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><object-id pub-id-type="doi">10.7554/eLife.47566.026</object-id><label>Figure 3—source data 4.</label><caption><title>Individual measurements of Rac1 and correlations between RhoA activation and growth (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2b,c,e–g</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata5"><object-id pub-id-type="doi">10.7554/eLife.47566.027</object-id><label>Figure 3—source data 5.</label><caption><title>Individual measurements of arbor parameters in control and RhoA KO mouse neurons (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3b–e</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-data5-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.018</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Long-term measurements of Rho-GTPase activation.</title><p>Raichu probes and RhoA-FLARE are generally used for short-term measurements, though they are in principle able to be calibrated (e.g., <xref ref-type="bibr" rid="bib69">Palmer et al., 2004</xref>) and measurements from 10 hr up to 8 days have been reported (<xref ref-type="bibr" rid="bib37">Kim et al., 2014</xref>; <xref ref-type="bibr" rid="bib40">Konopka et al., 2016</xref>; <xref ref-type="bibr" rid="bib94">Timpson et al., 2011</xref>). (<bold>a</bold>) Representative images of Cos-7 cells expressing Raichu-RhoA with the RhoA moiety mutated such that it is dominant negative (DN) or constitutively active (CA) taken from the same pool of cells 24 hr apart. (<bold>b</bold>) Summary data for this experiment. (N = 3, n = 30). (<bold>c</bold>) Representative images of Cos-7 cells expressing Raichu-RhoA and empty vector or the RhoA-GAP p190RhoGAP taken from the same pool 24 hr apart. (<bold>d</bold>) Summary data for this experiment. (N = 3, n = 80 for t = 0 hr and 60 for t = 24 hr) (<bold>e</bold>) Representative images of Cos-7 cells expressing Raichu-RhoA and empty vector or a Rac1-GAP-dead mutant of Bcr (i.e., a functional RhoA-GEF only) taken from the same pool of cells 24 hr apart. (<bold>f</bold>) Summary data for this experiment. (N = 3, n = 60 for t = 0 hr and 80 for t = 24 hr) (<bold>g</bold>) Representative images of Cos-7 cells expressing Raichu-Rac1 and empty vector or a RhoA-GEF-dead mutant of Bcr (i.e., a functional Rac1-GAP only) taken from the same pool of cells 24 hr apart. (<bold>h</bold>) Summary data for this experiment. (N = 3, n = 80) (<bold>i</bold>) Representative images of Cos-7 cells expressing Raichu-Rac1 and empty vector or the Rac1-GEF Tiam1 taken from the same pool of cells 24 hr apart. (<bold>j</bold>) Summary data for this experiment. (N = 3, n = 80 for t = 0 hr, 60 for vector t = 24 hr and 50 for Tiam1 t = 24 hr) (<bold>k</bold>) Summary data showing the quotient between measurements separated by 1 hr, taken from the experiments shown in <xref ref-type="fig" rid="fig3">Figure 3d–i</xref> at 18 DIV. These data show stability on a shorter time course that is comparable to the longer-term data that is presented in <xref ref-type="fig" rid="fig3">Figure 3</xref>. This is preserved across stable, retracting, and extending pools of dendrites and somata. (N = 5, n = 74 for somata, 115 for stable branches, 106 for stable tips, 134 for retracting branches, 131 for retracting tips, 96 for extending branches, and 94 or extending tips) Together, these data show that measurements are reasonably stable over 24 hr. Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig3s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.019</object-id><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b,d,f,h,j</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.020</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Effect of BAI1 Kd on dendritic Rac1 activation through development and lack of robust correlation of some RhoA parameters with dendrite growth.</title><p>(<bold>a</bold>) Representative images of hippocampal neurons expressing RaichuEV-Rac1 alone (control) or with shRNAs against <italic>Adgrb1</italic> (BAI1 Kd) measured at the indicated times. Overall dendrite structure was ascertained by directly exciting the FRET acceptor (YFP images), while relative Rac1 activation is shown in the FRET images according to the color code in the lower right corner (low values on the left, high on the right, see Methods). Note that population growth trajectories in the RaichuEV-Rac1 expressing were similar to those observed in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Images are masked to remove axons and dendrites from other neurons. Bar is 20 µm. (<bold>b</bold>) Summary data for Rac1 activation at dendrite tips. Total number of neurons: 51 and 52 for control and BAI1 Kd at 15 DIV, 54 and 41 at 17 DIV, 53 and 47 at 18 DIV, 41 and 36 at 20 DIV, 47 and 34 at 21 DIV, and 52 and 46 at 23 DIV (N = 5). There were no differences in Rac1 activation in control vs. BAI1 Kd neurons at dendrite tips (panels a,b), dendrite branch points (panels a,c), or whole dendrites (data not shown) until 20 DIV, when arborization differences in BAI1 Kd were already readily apparent (Panels d-f, <xref ref-type="fig" rid="fig2">Figure 2</xref>). Moreover, Rac1 was lower in BAI1 Kd neurons than in control neurons at 20 and 21 DIV, which would be expected to <italic>stunt</italic> dendritic growth. Thus, BAI1 signaling to Rac1 does not explain the phenomena exhibited in <xref ref-type="fig" rid="fig1">Figures 1</xref>–<xref ref-type="fig" rid="fig2">2</xref>. The elevation of Rac1 activation at dendrite tips at 23 DIV does indicate that Rac1 overactivation may drive dendrite overgrowth in BAI1 Kd neurons at or after the time frame of normal dendrite growth arrest on which we concentrate in this study. (<bold>d</bold>) Relative length trajectories for stable, retracting, and extending dendrites in control (circles, solid lines) and BAI1 Kd (squares, dashed lines). Maximum length of individuals throughout the time course was assigned a value of 1.0 and all other values calculated relative to this. Note that while the proportion of extending and retracting dendrites is different in control vs. BAI1 Kd neurons (<xref ref-type="fig" rid="fig3">Figure 3d</xref>), the extent to which individual dendrites extend or retract relative to their maximum length is the same in control and BAI1 Kd neurons. Total number of neurons is the same as in <xref ref-type="fig" rid="fig3">Figure 3i</xref>. e through g Correlation of different RhoA activation parameters in dendrites with dendrite growth behavior. All of the individual events between days in the time course shown in <xref ref-type="fig" rid="fig3">Figure 3e–f</xref> were pooled and arrayed as shown. Unlike the robust negative correlation between RhoA activation at dendrite tips shown in <xref ref-type="fig" rid="fig3">Figure 3i</xref>, the following correlations were not informative. Panel (<bold>e</bold>) shows the relationship between the change in RhoA activation at dendrite tips between time points and the accompanying changes in dendrite length. These changes were relatively small on average and the apparently positive correlation in the BAI1 Kd neurons is due to an outlier on the right whose ordinate is not significantly different from those of the other points in the BAI1 Kd series. Panel (<bold>f</bold>) shows the relationship between the change in RhoA activation at dendritic branch points and accompanying changes in dendrite length in control an BAI1 Kd neurons. The ordinates in the control pool have no significant differences, indicating that there is no relationship between the two. There is a positive correlation between the changes in RhoA activation at dendritic branch points and dendrite growth, indicating that these changes in RhoA activation may drive dendrite behavior in BAI1 Kd neurons, though they do not in wild type neurons. Panel (<bold>g</bold>) shows the correlation between the levels of RhoA at dendritic branch points and dendrite growth. There is negative correlation between these parameters in control neurons, and an even more robust negative correlation in BAI1 Kd neurons. These data further support the notion that RhoA activation levels at branch points drives dendrite growth in BAI1 Kd neurons, and this relationship is more compelling than that in Panel E. Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig3s2sdata1">Figure 3—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig3s2sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.021</object-id><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2b,c</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.022</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Loss of RhoA leads to late overgrowth of dendrites in mouse hippocampal neurons.</title><p>(<bold>a</bold>) Representative images of hippocampal cultures from RhoA<sup>flox/flox</sup> mice transfected with EGFP alone (Control) or EGFP plus Cre recombinase in order to remove RhoA (RhoA KO) and fixed at the indicated time points. Quadruplicate exemplars are shown. Images are masked to remove axons and dendrites from other neurons. Bar is 20 µm. (<bold>b</bold>) Summary data for dendrite length. (<bold>c</bold>) Summary data for dendrite number. (<bold>d</bold>) Summary data for braanch number. (<bold>e</bold>) Summary data for 1° dendrite number. Control mouse cultures achieved stable arbor length by 12 DIV, exhibiting no further growth at 19 DIV (Panels A,B). In contrast, RhoA KO neurons were the same length as control neurons at 12 DIV, but grew between 12 and 19 DIV (panels a,b). Interestingly, control neurons exhibited decreases in both dendrite number (panels a,c) and branch points (panels a,d) from 12 to 19 DIV, but RhoA KO neurons did not (panels a,c,d). RhoA KO had no effect on the number of primary dendrites (panels a,e). These data confirm that RhoA limits dendrite growth, primarily later in development. Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig3s3sdata1">Figure 3—figure supplement 3—source data 1</xref>.</p><p><supplementary-material id="fig3s3sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.023</object-id><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3b–e</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig3-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig3-figsupp3-v1.tif"/></fig></fig-group><p>That BAI1 signals to RhoA to effect a transition out of dendrite growth is an intriguing hypothesis, but the data linking RhoA to dendrite growth arrest are incomplete. To address this, we assayed dendrite arbor growth in hippocampal neurons from RhoA<sup>flox/flox</sup> mice (<xref ref-type="bibr" rid="bib62">Mulherkar et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Mulherkar et al., 2014</xref>). These experiments revealed that RhoA KO neurons exhibited increased arbor size and complexity relative to controls late in development (19 DIV) (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3a–e</xref>). But does RhoA activation drive dendrite behavior, and how does BAI1 affect this relationship? To answer these questions, we analyzed dendrites persistent from 16 to 21 DIV in hippocampal neurons expressing the RhoA FRET probe RhoA-flare (<xref ref-type="bibr" rid="bib72">Pertz et al., 2006</xref>). We classified all persistent dendrites as stable (&lt;10% change in length), extending (≥10% net growth), or retracting (≥10% net shrinkage). The proportions of these pools differed greatly between control and BAI1 Kd neurons: extending dendrites formed twice the share of total dendrites in BAI1 Kd neurons as in control neurons, with the reverse being true for retracting neurons; the proportion of stable neurons was essentially the same (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). In control neurons, RhoA activation correlated strikingly with individual dendrite behavior (<xref ref-type="fig" rid="fig3">Figure 3e,g,h</xref>): extending dendrites showed low levels of RhoA activation, while retracting dendrites had high levels thereof. These differences in RhoA activation were persistent throughout the time course and especially pronounced at the dendrite tips (<xref ref-type="fig" rid="fig3">Figure 3g</xref>, left), though also apparent at branch points (<xref ref-type="fig" rid="fig3">Figure 3h</xref>, left). BAI1 Kd profoundly affected these phenomena. BAI1 Kd neurons had lower RhoA activation levels throughout the time course (<xref ref-type="fig" rid="fig3">Figure 3f–h</xref>, right). At dendrite tips, which were the best indicators of dendrite behavior in control neurons, there was no difference in RhoA activation between extending and retracting dendrites in BAI Kd neurons (<xref ref-type="fig" rid="fig3">Figure 3f,g</xref>). The differences between RhoA activation in extending and retracting dendrites were maintained at branch points in BAI1 Kd neurons, though RhoA activation was generally lower than in control neurons (<xref ref-type="fig" rid="fig3">Figure 3f–h</xref>, right). These differences in RhoA activation do not merely arise from differences in dendrite behavior because within the stable, extending, and retracting dendrite populations, relative dendrite length changes were the same in control and BAI1 Kd neurons (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2d</xref>).</p><p>The population data for control neurons in <xref ref-type="fig" rid="fig3">Figure 3g&amp;h</xref> suggested that by 16 DIV, most persistent dendrites have established their fate with regard to extension or retraction. We gathered all of the individual dendrite growth/retraction events from our time courses into control and BAI1 Kd pools and sought to determine an empirical, quantitative rule that links RhoA activation to arbor behavior. The best match was shown in <xref ref-type="fig" rid="fig3">Figure 3i</xref>, wherein RhoA activation levels at dendrite tips strongly and negatively correlated with dendrite growth. BAI1 Kd, however, completely eliminated this correlation (<xref ref-type="fig" rid="fig3">Figure 3i</xref>). Correlation of dendrite growth with a number of other parameters was less informative (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2e–g</xref>). These data suggest that RhoA activation at dendritic tips is the primary driver of dendritic retraction in wild type neurons.</p></sec><sec id="s2-3"><title>BAI1 effects on dendritic arbors are rescued by compensatory changes in RhoA signaling</title><p>If BAI1 functions through RhoA to cause dendrite growth arrest, forced RhoA activation should compensate for BAI1 Kd. We tested this using narciclasine, which activates RhoA and is not neurotoxic up to 100 nM (<xref ref-type="bibr" rid="bib43">Krug et al., 2013</xref>). We first confirmed that narciclasine activated RhoA in neurons by treating Raichu-RhoA-expressing hippocampal neurons with vehicle or 10 nM narciclasine. Narciclasine-treated neurons exhibited increased RhoA activation throughout the dendritic arbor (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a,b</xref>). We therefore applied narciclasine to 17 DIV neurons and found that this low dose of narciclasine had no effect on the morphology of control neurons assayed on 21 DIV, but prevented BAI1 Kd-mediated dendrite overgrowth with respect to dendrite length (<xref ref-type="fig" rid="fig4">Figure 4a,b</xref>), dendrite number (<xref ref-type="fig" rid="fig4">Figure 4a,c</xref>), branch points (<xref ref-type="fig" rid="fig4">Figure 4a,d</xref>), and Sholl curves (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c,d</xref>). Like BAI1 Kd, narciclasine had no effect on primary dendrite number (<xref ref-type="fig" rid="fig4">Figure 4a,e</xref>). We also examined spine density and morphology under these conditions. As we have previously reported, BAI1 Kd caused decreases in spine density (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,b</xref>) and maximum diameter (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,e</xref>), but increases in filopod density (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,c</xref>) and spine length (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,d</xref>). Unlike dendritic arbor morphology, narciclasine did not rescue the spine density defects (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,b</xref>), though it did block increases in spine length (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,d</xref>) and decreased spine maximum diameter by itself (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,e</xref>), consistent with known effects of RhoA on spine morphology (<xref ref-type="bibr" rid="bib95">Tolias et al., 2011</xref>).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.029</object-id><label>Figure 4.</label><caption><title>BAI1 manipulations are rescued by compensatory changes in RhoA signaling.</title><p>(<bold>a</bold>) Representative somatodendritic images of hippocampal neurons transfected with EGFP alone (control) or with shRNA against <italic>Adgrb1</italic> (BAI1 Kd) treated with vehicle or 10 nM narciclasine at 17 DIV and fixed at 21 DIV. Images are masked to remove axons and dendrites from other neurons. Bar is 20 µm. (<bold>b</bold>) Summary data for dendrite length. (<bold>c</bold>) Summary data for dendrite number. (<bold>d</bold>) Summary data for branches. (<bold>e</bold>) Summary data for primary dendrites. Total number of neurons: 105 per condition (N = 3). (<bold>f</bold>) Representative somatodendritic images of hippocampal neurons transfected with EGFP alone (control) or with BAI1 (BAI1 OX) treated with vehicle or 2 µM Y-26732 at 17 DIV, fixed at 21 DIV and masked as in panel <bold>a. g</bold>) Summary data for dendrite length. (<bold>h</bold>) Summary data for dendrite number. (<bold>i</bold>) Summary data for branch number. (<bold>j</bold>) Summary data for primary dendrite number. Total number of neurons: 47 per condition (N = 4). Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p><p><supplementary-material id="fig4sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.037</object-id><label>Figure 4—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig4">Figure 4</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig4">Figure 4b–e,g–j</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.034</object-id><label>Figure 4—source data 2.</label><caption><title>Individual measurements of arbor parameters for neurons treated with narciclasine and Y-27632 (<xref ref-type="fig" rid="fig4">Figure 4b–e,g–j</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.035</object-id><label>Figure 4—source data 3.</label><caption><title>Individual measurements of narciclasine controls and Sholl analyses in narciclasine- and Y-27632-treated neurons (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b–g</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><object-id pub-id-type="doi">10.7554/eLife.47566.036</object-id><label>Figure 4—source data 4.</label><caption><title>Individual measurements of spine parameters in neurons treated with narciclasine (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b–e</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.030</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Verification of narciclasine function in neurons and Sholl analyses with RhoA manipulation.</title><p>(<bold>a</bold>) Representative image of hippocampal neurons expressing Raichu RhoA and treated with DMSO (Vehicle) or 10 nM narciclasine (10 nM Narc.) 1 hr after treatment. (<bold>b</bold>) Summary data for changes in RhoA activation during the 1 hr. incubation. (<bold>c</bold>) Summary data for Cos-7 cells expressing Raichu-RhoA or Raichu-Rac1 before (solid bars) or 20 min after (hatched bars) after treatment with 20 nM narciclasine. (N = 3, n = 20–40) <bold>d</bold>) and <bold>e</bold>) Summary data of Sholl analyses in vehicle-treated (<bold>c</bold>) and narciclasine-treated (<bold>d</bold>) control (black) and BAI1 Kd (green) neurons. Total number of neurons is the same as for <xref ref-type="fig" rid="fig4">Figure 4a–e</xref>. (<bold>f</bold>) and <bold>g</bold>) Summary data of Sholl analyses in vehicle-treated (<bold>e</bold>) and Y-27632-treated (<bold>f</bold>) control (black) and BAI1 OX (red) neurons. Total number of neurons is the same as for <xref ref-type="fig" rid="fig4">Figure 4f–j</xref>. (***p&lt;0.001, §p&lt;0.001 (green) between the two BAI1 Kd curves (green) in panels d and e, §p&lt;0.01 (red) between the two BAI1 OX curves (red) in panels f and g) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig4s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.031</object-id><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b–g</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.032</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Effect of narciclasine on dendritic spines.</title><p>(<bold>a</bold>) Representative segments of secondary dendrites reconstructed from 3D stacks of hippocampal neurons transfected with EGFP and vector (pSuper) or shRNA against <italic>Adgrb1</italic> (BAI1 Kd), treated with DMSO or 10 nM narciclasine at 17 DIV, and fixed at 21 DIV. Dendrite morphology is shown by EGFP (green), and neurons were also stained for BAI1 (red). (<bold>b</bold>) Summary data for spine density. (<bold>c</bold>) Summary data for filopod density. (<bold>d</bold>) Summary data for spine length. (<bold>e</bold>) Summary data for spine maximum diameter. Total number of neurons 30 for each condition (N = 3). Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig4s2sdata1">Figure 4—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig4s2sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.033</object-id><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2b–e</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig4-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig4-figsupp2-v1.tif"/></fig></fig-group><p>We next turned to the BAI1 gain-of-function phenotype. RhoA-dependent kinases, especially ROCK1/2, are implicated in dendrite growth arrest (<xref ref-type="bibr" rid="bib57">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib86">Sin et al., 2002</xref>; <xref ref-type="bibr" rid="bib67">Nakayama et al., 2000</xref>), so we tested the ability of the ROCK inhibitor Y-27632 to rescue dendritic arbors from the contraction caused by BAI1 OX (<xref ref-type="fig" rid="fig2">Figure 2</xref>). As with narciclasine, we used a low dose (2 µM) of Y-27632 that had no effect on control hippocampal neurons treated on 17 DIV and assayed on 21 DIV (<xref ref-type="fig" rid="fig4">Figure 4f</xref>). As above, BAI1 OX led to lower total dendrite length (<xref ref-type="fig" rid="fig4">Figure 4f,g</xref>), fewer dendrites (<xref ref-type="fig" rid="fig4">Figure 4f,h</xref>), fewer branch points (<xref ref-type="fig" rid="fig4">Figure 4f,i</xref>), and contracted Sholl curves (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f,g</xref>). All of these effects were prevented by Y-27632 (<xref ref-type="fig" rid="fig4">Figure 4f–i</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f–g</xref>). Y-27632 did not affect the number of primary dendrites (<xref ref-type="fig" rid="fig4">Figure 4f,j</xref>). Thus, modulating RhoA signaling with narciclasine (RhoA activation) or Y-27632 (ROCK inhibition) rescues dendritic arbors from the effects of altered BAI1 signals, suggesting a role for RhoA signaling downstream of BAI1.</p></sec><sec id="s2-4"><title>No previously described signaling function of BAI1 mediates RhoA activation or dendrite growth arrest</title><p>A growing body of research attests to the complexity, modularity, and variable outcomes of BAI1 signaling (<xref ref-type="bibr" rid="bib16">Duman et al., 2016</xref>). <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref> shows BAI1’s domain structure and summarizes the signaling pathways traced to specific BAI1 domains to date. There are four known intracellular signaling motifs in BAI1, and we tested each for their involvement in arbor growth restriction using a molecular replacement strategy. BAI1 has been linked to Rho-family GTPase guanine-nucleotide exchange factors (Rho-GEFs), which activate Rho-family small GTPases, through three motifs: (i) the PDZ domain-binding TEV motif at the extreme C-terminus of the protein, which recruits the Rac1-GEF complex Tiam1/Par3 in neurons (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>), (ii) a helical domain that recruits and activates the Rac1-GEF complex ELMO/DOCK180 in a ligand-dependent manner (<xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>), and (iii) the GPCR domain, which couples to Gα<sub>12/13</sub> and activates RhoA (<xref ref-type="bibr" rid="bib89">Stephenson et al., 2013</xref>). Deletion or mutation of each of these domains resulted in well-expressed mutants that are surface-localized (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2a,b</xref> and <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>) and capable of rescuing BAI1 Kd-induced increases in dendrite length, number, and branches as effectively as wild-type BAI1 (<xref ref-type="fig" rid="fig5">Figure 5a–c,f–h</xref>). It is especially interesting that the ∆TEV BAI1 mutant rescued arbor growth arrest, as it does not rescue spine development (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>), arguing against BAI1’s effect on arbors arising as a secondary effect from its effects on synaptogenesis. To further address this point, we demonstrated that suppression of activity did not cause arbor overgrowth in control hippocampal neurons, nor did increasing activity prevent overgrowth in BAI1 Kd neurons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1h,i</xref>). We also deleted a proline-rich region that links BAI1 to the scaffold IRSp53 (<xref ref-type="bibr" rid="bib68">Oda et al., 1999</xref>), and found that this mutant also rescued BAI1 Kd-mediated dendrite overgrowth (<xref ref-type="fig" rid="fig5">Figure 5d,f–h</xref>). Neither BAI1 Kd nor any of the mutants affected primary dendrite number (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b</xref>), and all mutants were expressed at levels comparable to wild-type BAI1 (<xref ref-type="fig" rid="fig5">Figure 5a–e</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1c–f</xref>). In sum, no previously reported BAI1 signaling modality is necessary for restricting dendrite growth.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.038</object-id><label>Figure 5.</label><caption><title>BAI1 requires its extracellular segment to inhibit dendrite growth, but does not employ any known intracellular signaling modality to do so.</title><p>a through e Representative images of neurons expressing EGFP and control vector (Control), shRNA against <italic>Adgrb1</italic> (BAI1 Kd), or shRNAs against BAI1 plus RNAi-resistant BAI1 (Wt rescue) or an RNAi-resistant BAI1 mutant (Mut. rescue). All images are masked to remove axons and dendrites from other neurons. The mutant used for rescue in each series is shown in cartoon form on the left. Mutants used included a deletion of the PDZ-binding core sequence (<bold>a</bold>), an RKR→AAA mutation in the helical domain that prevents ELMO1 binding (<bold>b</bold>), deletion of all but the first transmembrane domain of the GPCR domain (<bold>c</bold>), deletion of the proline-rich region (<bold>d</bold>), and deletion of the entire N-terminal extracellular segment between the signal sequence and the native autoproteolysis site (<bold>e</bold>). Representative EGFP images of the entire arbor are on top (bar is 20 µm), while EGFP and BAI1 immunochemistry images reconstructed from 3D confocal stacks of secondary dendrites taken from the same experiments are shown immediately under these (bar is 2.5 µm). (<bold>f</bold>) Summary data for dendrite length. (<bold>g</bold>) Summary data for dendrite number. (<bold>h</bold>) Summary data for branch number. Total number of neurons: 314 for control neurons (N = 24), 288 for BAI1 Kd neurons (N = 24), 235 for wt rescue neurons (N = 24), 29 for ∆TEV rescue neurons (N = 3), 86 for RKR rescue neurons (N = 9), 39 for ∆GPCR neurons (N = 3), 72 for ∆PRR neurons (N = 3), and 37 for (N = 3) for ∆Nterm. rescues. Data are represented ± s.e.m. (<sup>a</sup>P &gt;0.05 within group <italic>a</italic>, but p&lt;0.05 vs. group <italic>b</italic>; <sup>b</sup>P &gt;0.05 within group <italic>b</italic>, but p&lt;0.05 vs. group <italic>a</italic>.) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.044</object-id><label>Figure 5—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig5">Figure 5</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig5">Figure 5f–h</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.042</object-id><label>Figure 5—source data 2.</label><caption><title>Individual measurements of dendritic parameters in control neurons and those with molecular replacements with BAI1 mutants (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig5-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.043</object-id><label>Figure 5—source data 3.</label><caption><title>Individual measurements of primary dendrites in molecular replacement experiments and dendrite arbor lengths when neuronal activity is modulated (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b,i</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig5-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.039</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Signaling pathways downstream of BAI1; 1° dendrites in molecular replacement studies; and effect of activity on arbor form.</title><p>(<bold>a</bold>) Cartoon showing the domain structure of BAI1 (left), along with functions traced to different intracellular domains of BAI1. Connections depicted in solid lines indicate published connections to BAI1, while dotted lines show published relationships between downstream effectors of BAI1 and other signaling components that have not (yet) been definitively linked to BAI1. Abbreviations: RGD: arginine-glycine-aspartate integrin-binding motif; TSRs: thrombospondin repeats; HBD: hormone-binding domain; GAIN: G-protein autoproteolysis inducing domain; GPCR: G-protein coupled receptor domain; PRR: proline-rich region; HD: helical domain; and PBM: TEV-based PDZ-binding motif (<xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>; <xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Duman et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Stephenson et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Ridley, 2006</xref>; <xref ref-type="bibr" rid="bib32">Kang et al., 2016</xref>). (<bold>b</bold>) Summary data for 1° dendrite number in the molecular replacement studies shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>. <sup>a</sup>P &gt;0.05 within group <italic>a</italic>, but p&lt;0.05 vs. group <italic>b</italic>; <sup>b</sup>P &gt;0.05 within group <italic>b</italic>, but p&lt;0.05 vs. group <italic>a</italic>. Total number of neurons is the same as in <xref ref-type="fig" rid="fig5">Figure 5</xref>. c through g Representative images of sections of dendrites from the neurons in <xref ref-type="fig" rid="fig6">Figure 6</xref> with BAI1 staining. These images are digital enlargements of the neurons shown in the figure to indicate relative BAI1 levels. Panel c shows the experiment with the ∆TEV mutant, panel d with the RKR mutant, panel e with the ∆GPCR mutant, panel f with the ∆PRR mutant, and panel g with the ∆Nterm. mutant. In panels c and f, the dendrite segment impinges on the cell body of an untransfected neuron, indicated by a *. These images show that the neurons shown in <xref ref-type="fig" rid="fig5">Figure 5</xref> express the appropriate levels of BAI1 for their respective conditions. (<bold>h</bold>) Representative images of hippocampal neurons transfected pSuper or shRNA against <italic>Adgrb1</italic> (BAI1 Kd) and treated with the indicated drugs at 17 DIV and imaged at 21 DIV. Treatments included a vehicle control (Veh.), tetrodotoxin to silence neurons (TTX), potassium chloride to increase neuronal excitability (KCl), and AP5 to block NMDA receptors (AP5). All images were masked to exclude axons and dendrites from other neurons. (<bold>i</bold>) Summary data of arbor length. Total number of neurons: 95 for control vehicle, 81 for BAI1 Kd vehicle, 41 for control TTX, 49 for BAI1 Kd TTX, 69 for control KCl, 54 for BAI1 Kd KCl, 75 for control AP5, and 63 BAI1 Kd AP5 (N = 5). Data are represented ± s.e.m. . (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig5s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.040</object-id><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and summary of ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b, i</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.041</object-id><label>Figure 5—figure supplement 2.</label><caption><title>Surface labeling of BAI1 and mutants.</title><p>(<bold>a</bold>) Representative images of Cos-7 cells expressing EGFP and empty vector (Control), wild-type BAI1 (BAI1) or the indicated BAI1 mutants live surface labeled using a polyclonal antibody against an extracellular N-terminal epitope on BAI1, then washed, fixed, permeabilized and labeled with an antibody against the intracellular C-terminal tail of BAI1. Shown are the EGFP expression, N-terminal labeling (live, N-terminal), total BAI1 labeling (permeabilized, C-terminal), and an overlay of all of these signals. (<bold>b</bold>) Representative images of an experiment identical to that in panel a, but live labeled with the C-terminal antibody instead of the N-terminal antibody. The ∆N-term. mutant was not amenable to this analysis because it does not contain the N-terminal epitope. However, we previously demonstrated that this mutant is surface localized using an N-terminal flag-tag (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). All experiments were repeated three independent times with similar results.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig5-figsupp2-v1.tif"/></fig></fig-group><p>Additionally, we deleted the N-terminal segment of BAI1 between the signal sequence and GPS motif within its GAIN domain (see <xref ref-type="fig" rid="fig5">Figure 5</xref> legend and discussion), mimicking an archetypal A-GPCR intramolecular cleavage (<xref ref-type="bibr" rid="bib24">Hamann et al., 2015</xref>). This segment contains a number of motifs and domains that have putative or demonstrated ligand-binding functions (<xref ref-type="bibr" rid="bib24">Hamann et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Langenhan et al., 2013</xref>; <xref ref-type="bibr" rid="bib105">Yona et al., 2008</xref>). BAI1-∆N-term. traffics to the cell surface, expresses well, and localizes to dendrites (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref> and <xref ref-type="fig" rid="fig5">Figure 5e</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1g</xref>). However, unlike the other mutants, it did not rescue dendritic overgrowth in BAI1 Kd neurons (<xref ref-type="fig" rid="fig5">Figure 5e,f–h</xref>). Thus, extracellular ligand binding is likely required for BAI1-mediated arbor growth arrest.</p><p>Our panel of mutants (<xref ref-type="fig" rid="fig5">Figure 5</xref>) allowed us to further verify the relationship between dendrite growth and RhoA activation. As shown previously, BAI1 Kd neurons had clearly lower levels of RhoA activation throughout their somatodendritic domains (<xref ref-type="fig" rid="fig6">Figure 6a</xref>), and especially at dendrite tips (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). Both dendrite overgrowth and lowered RhoA activation were rescued by the expression of RNAi-resistant BAI1 (<xref ref-type="fig" rid="fig6">Figure 6a,b</xref>). Further, all of the BAI1 mutants that rescued dendrite overgrowth (∆TEV, RKR, ∆GPCR, and ∆PRR) also rescued RhoA activation, while BAI1-∆N-term. failed to rescue both defects (<xref ref-type="fig" rid="fig6">Figure 6a,b</xref>). Taken together, these results strongly suggest that BAI1 functions through RhoA to mediate dendritic arbor growth arrest.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.045</object-id><label>Figure 6.</label><caption><title>Proper RhoA activation is required for rescue of the BAI1 Kd-mediated dendrite overgrowth.</title><p>(<bold>a</bold>) Representative images of hippocampal neurons expressing the RhoA activation reporter RhoA-FLARE, along with control vector (control), shRNA against <italic>Adgrb1</italic> (BAI1 Kd), or shRNA against BAI1 and RNAi-resistant BAI1 (Wt rescue) or the indicated RNAi-resistant mutants (see <xref ref-type="fig" rid="fig6">Figure 6</xref>). The 4-panel cluster for each condition consists of an image of the complete somatodendritic domain obtained by direct excitation of the acceptor (YFP images, upper left; bar is 20 µm), a map of RhoA activation color-coded according the scale in <xref ref-type="fig" rid="fig3">Figure 3</xref> (RhoA Act., upper right), and digitally magnified stretches of dendrite showing morphology obtained by direct excitation of the acceptor (YFP, lower left; bar is 5 µm), and BAI1 immunostaining (BAI1, lower right). Images are masked to remove axons and dendrites from other neurons. (<bold>b</bold>) Summary data of RhoA activation at dendritic tips. Total number of dendrite tips: 670 for controls, 495 for BAI1 Kd, 630 for wt rescues, 640 for ∆TEV rescues, 60 for RKR rescues, 40 for ∆GPCR rescues, 635 for ∆PRR rescues, and 55 for ∆Nterm. rescues (N = 5). Data are represented ± s.e.m. (<sup>a</sup>P &gt;0.05 within group <italic>a</italic>, but p&lt;0.05 vs. group <italic>b</italic>; <sup>b</sup>P &gt;0.05 within group <italic>b</italic>, but p&lt;0.05 vs. group <italic>a</italic>.) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p><p><supplementary-material id="fig6sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.047</object-id><label>Figure 6—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig6">Figure 6</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for (<xref ref-type="fig" rid="fig6">Figure 6b</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.046</object-id><label>Figure 6—source data 2.</label><caption><title>Individual measurements of RhoA activation at dendrite tips in molecular replacement experiments (<xref ref-type="fig" rid="fig6">Figure 6b</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig6-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig6-v1.tif"/></fig></sec><sec id="s2-5"><title>Bcr links BAI1 to RhoA and dendritic growth arrest</title><p>How does BAI1 regulate RhoA in the context of dendritic growth arrest? We performed a small screen in which we immobilized BAI1’s intracellular C-terminal tail on glutathione resin and assayed its interaction with dendritic RhoA regulatory proteins. In so doing, we identified the related proteins breakpoint cluster region (Bcr) and activated Bcr-related (Abr) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1a</xref>), both of which restrict dendritic growth via inhibition of Rac1, but also have putative RhoA-GEF domains (<xref ref-type="bibr" rid="bib99">Um et al., 2014</xref>). We confirmed these interactions by immunoprecipitation from hippocampal neurons. Interestingly, we detected little or no interaction between BAI1 and Bcr before DIV 17, but the interaction was readily detected at the time of dendritic growth arrest (<xref ref-type="fig" rid="fig7">Figure 7a–c</xref>). No interaction was detected between BAI1 and Abr (<xref ref-type="fig" rid="fig7">Figure 7a,b</xref>).</p><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.048</object-id><label>Figure 7.</label><caption><title>BAI1 signals to RhoA via Bcr.</title><p>(<bold>a</bold>) Representative Western blots of Bcr, Abr, and BAI1 from primary hippocampal postnuclear supernatants (PNS) prepared at the indicated times from the same preparation. (<bold>b</bold>) Representative immunoprecipitations from the PNSs in panel a using an antibody against the C-terminus of BAI1 or non-immune serum (NI). A lane was removed from this blot due to a loading irregularity, and this is marked by an asterisk (*). (<bold>c</bold>) Summary data of Bcr band intensity from the experiment in panels a and b. Total number of preparations: N = 5. (<bold>d</bold>) Representative images of hippocampal neurons expressing EGFP and control shRNA vector (pSuper) or shRNA against <italic>Adgrb1</italic> (BAI1 Kd) and control myc-vector (vector), myc-tagged Bcr, or myc-tagged Abr. (<bold>e</bold>) Summary data of dendrite length in the experiment in panel d. (<bold>f</bold>) Summary data of dendrite and branch number in the experiment in panel d. (<bold>g</bold>) Scatter plot of dendrite length vs. quantified myc level in Vector pSuper neurons including a linear fit of the data. (<bold>h</bold>) Same as panel g, except for Bcr BAI1 Kd neurons. (<bold>i</bold>) Slopes of the lines in panels g and h, shown with 95% confidence intervals. (<bold>j</bold>) Representative images of Cos-7 cells expressing Raichu-RhoA and the indicated combinations of BAI1 and Bcr. RhoA activation is shown in the FRET images according to the color code in the lower right corner (low values on the left, high on the right). (<bold>k</bold>) Summary data of RhoA activation at the plasma membrane. Total number of cells: 452 for all conditions (N = 10). Data are represented ± s.e.m. except for panel i. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p><p><supplementary-material id="fig7sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.053</object-id><label>Figure 7—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig7">Figure 7</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig7">Figure 7c,e,f,k</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig7-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.051</object-id><label>Figure 7—source data 2.</label><caption><title>Individual measurements of Western blot bands, arbor parameters with Bcr and Abr, and Cos-7 RhoA activation (<xref ref-type="fig" rid="fig7">Figure 7c,e,f,k</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig7-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><object-id pub-id-type="doi">10.7554/eLife.47566.052</object-id><label>Figure 7—source data 3.</label><caption><title>Individual measurements of Rac1 activation in control, Abr-, and Bcr-expressing neurons (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1c</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig7-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47566.049</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Bcr functionally interacts with BAI1, while Abr does not.</title><p>(<bold>a</bold>) Representative blot of an experiment in which the intracellular C-terminus of BAI1 was immobilized on GST-agarose and incubated with adult rat brain lysate. After washing, samples were separated on SDS-PAGE and subjected to Western blotting for various RhoA regulatory proteins. Neuronal lysates are shown as a positive control, and GST-agarose as a negative control. This experiment was repeated three times. (<bold>b</bold>) Representative images of neurons expressing the Rac1 activity reporter RaichuEV and empty vector, Bcr, or Abr at 21 DIV. The scale for Rac1 activation is located in the lower right corner of the Abr image. (<bold>c</bold>) Summary data of Rac1 activation. Total number of neurons: 33 for control neurons, 33 for Bcr neurons, and 29 for Abr neurons. Data are represented ± s.e.m. (<bold>d</bold>) Scatter plot of dendrite length vs. quantified myc level in Vector pSuper neurons including a linear fit of the data. (<bold>e</bold>) Same as panel d, except for Abr BAI1 Kd neurons. Note the similarity of the slopes (axes are the same) in the two panels. (<bold>f</bold>) Western blot of Cos-7 extracts from the experiment shown in <xref ref-type="fig" rid="fig7">Figure 7k</xref>. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found in <xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig7s1sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.050</object-id><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1c</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig7-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig7-figsupp1-v1.tif"/></fig></fig-group><p>If BAI1 is required to activate the RhoA-GEF activity of Bcr and/or Abr, then it is possible that their overexpression might compensate for BAI1 loss. We tested this in hippocampal neurons. BAI1 Kd led to longer, more complex arbors as before, and both Bcr and Abr overexpression led to contracted arbors (<xref ref-type="fig" rid="fig7">Figure 7d–f</xref>) as previously reported (<xref ref-type="bibr" rid="bib71">Park et al., 2012</xref>). However, Bcr OX balanced BAI1 Kd, giving rise to arbors of normal length and complexity while Abr OX did not (<xref ref-type="fig" rid="fig7">Figure 7d–f</xref>). This difference could not be explained by differences in Rac1 inhibitory activity (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1b,c</xref>). Moreover, the effectiveness of Bcr in causing arbor contraction, assayed by the final arbor length as a function of Bcr OX level, was blunted by BAI1 loss (<xref ref-type="fig" rid="fig7">Figure 7g–i</xref>). This supports the idea that BAI1 activates Bcr RhoA-GEF activity in neurons. No such functional interaction with Abr was detected (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1d,e</xref>). Thus, both the biochemical and functional data support a role for Bcr in BAI1 signaling rather than Abr.</p><p>Despite sequence predictions that Bcr is a RhoA-GEF, there is little evidence that it functions in this capacity outside of the pathological Bcr-Abl fusion (see discussion). We detected RhoA activation in response to Bcr expression in Cos-7 cells (<xref ref-type="fig" rid="fig7">Figure 7j,k</xref>). Moreover, co-expression with BAI1 greatly enhanced Bcr RhoA-GEF activity (<xref ref-type="fig" rid="fig7">Figure 7j,k</xref>), despite comparable expression of the proteins in the cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1f</xref>), suggesting that BAI1 stimulates this activity. Is this Bcr-RhoA-GEF activity required for dendrite growth arrest? We tested this using hippocampal neurons isolated from Bcr<sup>–/–</sup> mice and wild-type littermates. As previously reported (<xref ref-type="bibr" rid="bib71">Park et al., 2012</xref>), Bcr loss caused dendritic overgrowth that was rescued by expression of wild type Bcr (<xref ref-type="fig" rid="fig8">Figure 8a–c</xref>). Strikingly, when the rescue was attempted using mutants of Bcr deficient for either Rac1-GAP (as previously reported [<xref ref-type="bibr" rid="bib71">Park et al., 2012</xref>]) or RhoA-GEF activity, neither dendritic length (<xref ref-type="fig" rid="fig8">Figure 8b</xref>) nor dendrite number (<xref ref-type="fig" rid="fig8">Figure 8c</xref>) was rescued. These results could not be explained by lower expression of the mutants (<xref ref-type="fig" rid="fig8">Figure 8a</xref>). To test whether both of these activities are required to complement the loss of BAI1, we performed an experiment analogous to that shown in <xref ref-type="fig" rid="fig7">Figure 7d–f</xref>, using the Bcr mutants in place of Abr. Overexpression of neither mutant rescued BAI1 Kd-mediated dendrite overgrowth in rat hippocampal neurons assayed by length (<xref ref-type="fig" rid="fig8">Figure 8d,e</xref>) or dendrite number (<xref ref-type="fig" rid="fig8">Figure 8d,f</xref>). These results suggest that BAI1-orchestrated dendrite growth arrest requires RhoA activation by Bcr downstream of BAI1 in concert with the Rac1-GAP activity of Bcr. This suggests that dendrite growth arrest requires a great change in the signaling environment within dendrites akin to a state change.</p><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.054</object-id><label>Figure 8.</label><caption><title>Both the RhoA-GEF and Rac1-GAP functions of Bcr are required for dendrite growth arrest.</title><p>(<bold>a</bold>) Representative images of mouse neurons with the indicated genotype expressing EGFP, pSuper or shRNA against <italic>Adgrb1,</italic> and empty vector (Vector), wild-type Bcr (Bcr), GAP-dead Bcr (Bcr-GAP<sup>–</sup>), or GEF-dead Bcr (Bcr-GEF<sup>–</sup>). All cells within a row were cultured from the same individual mouse. (<bold>b</bold>) Summary data of dendrite length. (<bold>c</bold>) Summary data for dendrite numbers and branches. Total number of neurons: 147 for Bcr<sup>+/+</sup> Vector, 82 for Bcr<sup>+/+</sup> Bcr, 69 Bcr<sup>+/+</sup> Bcr-GAP<sup>–</sup>, 69 Bcr<sup>+/+</sup>-GEF<sup>–</sup>, 177 for Bc<sup>r–/–</sup> Vector, 99 for Bcr<sup>–/–</sup> Bcr, 75 Bcr<sup>–/–</sup> Bcr-GAP<sup>–</sup>, and 109 for Bcr<sup>–/–</sup> Bcr-GEF<sup>–</sup> (N = 6–12). (<bold>d</bold>) Representative images of rat neurons expressing EGFP and pSuper or BAI1 Kd and the vectors as described in panel a. (<bold>e</bold>) Summary data of dendrite length. (<bold>f</bold>) Summary data of dendrite number and branches. Total number of neurons: 52 for pSuper Vector, 52 for pSuper Bcr, 37 pSuper Bcr-GAP<sup>–</sup>, 60 for pSuper Bcr-GEF<sup>–</sup>, 34 for BAI1 Kd Vector, 43 BAI1 Kd Bcr, 33 BAI1 Kd Bcr-GAP<sup>–</sup>, and 47 BAI1 Kd Bcr-GEF<sup>–</sup> (N = 5). Data are represented ± s.e.m. (***p&lt;0.0001, **p&lt;0.01, *p&lt;0.05) Detailed statistics are found sin <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>.</p><p><supplementary-material id="fig8sdata1"><object-id pub-id-type="doi">10.7554/eLife.47566.056</object-id><label>Figure 8—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig8">Figure 8</xref>: ANOVA and key Tukey <italic>post-hoc</italic> tests and N and n values for <xref ref-type="fig" rid="fig8">Figure 8b,c,e,f</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig8-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><object-id pub-id-type="doi">10.7554/eLife.47566.055</object-id><label>Figure 8—source data 2.</label><caption><title>Individual arbor parameters for mouse and rat neurons expressing different forms of Bcr <xref ref-type="fig" rid="fig8">Figure 8B,C,E,F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-47566-fig8-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We show here that lack of BAI1 in hippocampal neurons leads to longer, more complex, less stable dendritic arbors in culture and in vivo, whereas BAI1 overexpression leads to dendrite retraction. Strikingly, both defects manifest only late in development when dendritic arbors are transitioning from growth to maintenance, despite BAI1 having been manipulated well before this time. None of the previously known BAI1 signaling mechanisms accounts for dendritic growth arrest; rather, BAI1 couples to the small GTPase RhoA through Bcr independently of its GPCR moiety. RhoA is known to inhibit dendritic growth (<xref ref-type="bibr" rid="bib86">Sin et al., 2002</xref>; <xref ref-type="bibr" rid="bib103">Wong et al., 2000</xref>; <xref ref-type="bibr" rid="bib67">Nakayama et al., 2000</xref>; <xref ref-type="bibr" rid="bib52">Lee et al., 2000</xref>; <xref ref-type="bibr" rid="bib56">Li et al., 2000</xref>; <xref ref-type="bibr" rid="bib79">Ruchhoeft et al., 1999</xref>), but the dynamics of RhoA activation throughout dendritic development are not well understood (see below). BAI1 loss postpones and attenuates the previously unreported peak of RhoA activation coincident with dendrite growth arrest. Moreover, BAI1 loss globally suppresses RhoA activity and uncouples dendritic growth from RhoA activation at the tips, which seems to drive dendritic behavior late in development. This Bcr-dependent activation of RhoA, however is not sufficient to cause growth arrest but also requires Bcr-mediated inhibition of the complementary small GTPase Rac1. These results strongly implicate a BAI1-Bcr-RhoA pathway in regulating dendritic volume in the hippocampus, which is intriguing, especially given the links between BAI1 and ASD (<xref ref-type="bibr" rid="bib60">Michaelson et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Chahrour et al., 2008</xref>; <xref ref-type="bibr" rid="bib100">Urdinguio et al., 2008</xref>).</p><p>We previously reported that BAI1 Kd also causes a marked decrease in spine density in both cultured hippocampal neurons and in vivo in CA1 and cortical pyramidal neurons (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). That BAI1 Kd leads to a loss of dendritic spines and synapses in hippocampal neurons (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>) could be misconstrued as the explanation for the longer arbors reported here. Specifically, if low synapse density prevents BAI1 Kd neurons from achieving a synaptic ‘quota’ (i.e. reaching a set level of activity), neurons may compensate by extending their dendrites, possibly by inhibiting RhoA. This resembles the behavior of the <italic>Drosophila</italic> aCC motoneuron, whose arbor expands when deprived of afferent inputs (<xref ref-type="bibr" rid="bib96">Tripodi et al., 2008</xref>). However, our data are inconsistent with this explanation. First, the BAI1•∆TEV mutant rescues both the dendrite overgrowth (<xref ref-type="fig" rid="fig5">Figure 5a,f–h</xref>) and the decreased dendritic RhoA activation (<xref ref-type="fig" rid="fig6">Figure 6</xref>) effects of BAI1 Kd, whereas it does <italic>not</italic> rescue the spine deficits (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref> and <xref ref-type="fig" rid="fig5">Figure 5a</xref>), indicating that arbor and spine development are independently regulated by BAI1. Second, ectopic RhoA activation rescues arbor overgrowth (<xref ref-type="fig" rid="fig4">Figure 4a–d</xref>), but does not rescue spine loss (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a,b</xref>), again demonstrating the independence of these effects. Finally, hippocampal neurons do not overgrow when either NMDA receptors or voltage-gated Na<sup>+</sup> channels are blocked, nor does increasing neural activity cause retraction of BAI1 Kd neurons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1h,i</xref>). Thus, we can affirm that the effect of BAI1 on dendritic arbors is not a side effect of synapse loss. Is this result unexpected? Recently, two independent groups ablated presynaptic glutamate in the hippocampus using different strategies, and both showed relatively normal dendritic arbor length with no evidence of overgrowth in either CA1 pyramidal neurons or dentate granule cells at P21 (<xref ref-type="bibr" rid="bib80">Sando et al., 2017</xref>; <xref ref-type="bibr" rid="bib85">Sigler et al., 2017</xref>). Moreover, dendritic hypertrophy is independent of synapse dysfunction in the PTEN mouse model of ASD (<xref ref-type="bibr" rid="bib88">Sperow et al., 2012</xref>). Thus, while neural activity can greatly affect the length, form, and/or orientation of some neurons’ dendrites (<xref ref-type="bibr" rid="bib54">Lefebvre et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Dong et al., 2015</xref>), this does not appear to be the case for hippocampal neurons. Therefore, we conclude that BAI1’s role in restricting arbor growth is independent of its effect on promoting dendritic spinogenesis/synaptogenesis, and is mediated by the activation of RhoA by Bcr.</p><p>A recent study characterizing global BAI1 KO mice reported no change in dendritic arbor length or spine density as a result of BAI1 loss, though no quantitative dendritic data were presented (<xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>). These animals have diminished hippocampus-based learning, lowered threshold for LTP, LTP in response to LTD-provoking stimuli, and decreased PSD thickness (<xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>). BAI1 KO mice also have decreased levels of the postsynaptic scaffold PSD95, which we also reported in our sparse Kd models (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>), and BAI1 stabilizes PSD95 by binding to and inhibiting the E3 ubiquitin ligase MDM2 (<xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>). While these results of Zhu et al. may seem to be at odds with ours, this is not necessarily the case. First, Zhu et al. did not account for potential compensation by BAI2 and/or BAI3 (<xref ref-type="bibr" rid="bib84">Shiratsuchi et al., 1997</xref>), while our sparse, acute manipulations of neurons did not elicit any such compensation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Further, BAI1 may assert its effects by conferring an advantage to synapses and/or a disadvantage to dendrites that express it. If this were the case, then global loss of BAI1 would even the playing field and the effects of its loss might be greatly ameliorated. A similar situation may exist for the ASD-associated adhesion protein neuroligin-1 (NL1). While NL1 plays a crucial role in synaptic function, global NL1 KO is associated with essentially no effect on spine or synapse density (<xref ref-type="bibr" rid="bib47">Kwon et al., 2012</xref>). However, if NL1 is removed from a sparse population of neurons, these neurons exhibit dramatically lower spine and synapse densities (<xref ref-type="bibr" rid="bib47">Kwon et al., 2012</xref>); conversely, if NL1 is overexpressed sparsely, these neurons display higher spine densities and larger spines (<xref ref-type="bibr" rid="bib9">Dahlhaus et al., 2010</xref>). Interestingly, we recently demonstrated a functional interaction between BAI1 and NL1 in hippocampal neurons (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). Based on these considerations, we submit that BAI1 confers an advantage to synapses and a disadvantage to dendritic branches that express it during development. These effects are apparent when BAI1 is overexpressed or knocked down on a background of neurons normally expressing BAI1 in culture or in vivo, but that global removal of BAI1 removes this competitive advantage/disadvantage and makes the effects of BAI1 much less evident.</p><p>Bcr possesses multiple functional domains, but its most intriguing feature may be that it possesses a Rac1-GAP domain and a RhoA-GEF domain (<xref ref-type="bibr" rid="bib71">Park et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Rochelle et al., 2013</xref>; <xref ref-type="bibr" rid="bib93">Tala et al., 2013</xref>). Bcr was previously shown to restrict dendrite development and spinogenesis/synaptogenesis through its Rac1-GAP functionality (<xref ref-type="bibr" rid="bib99">Um et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Park et al., 2012</xref>), so the requirement for RhoA-GEF activity was unexpected. This activity of Bcr has mostly been described in the context of the p210<sup>bcr-abl</sup> fusion from the Philadelphia chromosome that is associated with virtually all cases of chronic myeloid leukemia, and activates RhoA and various downstream targets thereof (<xref ref-type="bibr" rid="bib77">Rochelle et al., 2013</xref>; <xref ref-type="bibr" rid="bib93">Tala et al., 2013</xref>). A physiological role for Bcr’s RhoA-GEF activity has been suggested in keratinocyte differentiation, though there is no obvious role for its Rac1-GAP activity in this system (<xref ref-type="bibr" rid="bib14">Dubash et al., 2013</xref>). Our results indicate that Bcr must <italic>both</italic> activate an inhibitor of arborization (RhoA) <italic>and</italic> inhibit an activator of arborization (Rac1) in order to precipitate arbor growth arrest (<xref ref-type="fig" rid="fig8">Figure 8</xref>). This suggests that the arrest signal is very high in magnitude, and perhaps requires multiple inputs.</p><sec id="s3-1"><title>BAI1, RhoA, and dendrite growth</title><p>Like all small GTPases, RhoA cycles between a GDP-bound inactive form and a GTP-bound active form (<xref ref-type="bibr" rid="bib18">Evers et al., 2000</xref>; <xref ref-type="bibr" rid="bib76">Ridley, 2006</xref>). Activated RhoA generally mediates inhibitory/repulsive processes in the nervous system (<xref ref-type="bibr" rid="bib75">Redmond and Ghosh, 2001</xref>). While RhoA is widely accepted as a physiological antagonist of dendrite growth in a variety of model systems, the studies on which this notion was built primarily employed dominant negative and constitutively active RhoA mutants (<xref ref-type="bibr" rid="bib86">Sin et al., 2002</xref>; <xref ref-type="bibr" rid="bib103">Wong et al., 2000</xref>; <xref ref-type="bibr" rid="bib67">Nakayama et al., 2000</xref>; <xref ref-type="bibr" rid="bib52">Lee et al., 2000</xref>; <xref ref-type="bibr" rid="bib56">Li et al., 2000</xref>; <xref ref-type="bibr" rid="bib79">Ruchhoeft et al., 1999</xref>) or studied the process at a much earlier stage (<xref ref-type="bibr" rid="bib92">Takano et al., 2017</xref>). We now know that overexpression of either type of GTPase mutant has great potential for broad-spectrum effects that cannot definitively be attributed to the target Rho-GTPase (<xref ref-type="bibr" rid="bib81">Schiller, 2006</xref>; <xref ref-type="bibr" rid="bib102">Vega and Ridley, 2007</xref>). However, more recent studies have verified the core finding that RhoA acts to oppose dendrite growth and expanded the contexts within which this might happen: RhoA activation by Arhgef1 opposes dendrite growth in mouse cortex at very early (&gt;P5) stages (<xref ref-type="bibr" rid="bib104">Xiang et al., 2016</xref>); RhoA activation by the neuropeptide orphanin FQ opposes developmental BDNF-stimulated dendrite growth in granule cells of the dentate gyrus (<xref ref-type="bibr" rid="bib1">Alder et al., 2013</xref>); RhoA inhibits the expression of the branch promoter cypin (<xref ref-type="bibr" rid="bib5">Chen and Firestein, 2007</xref>); failure to inactivate RhoA late in development leads to dendrite loss (<xref ref-type="bibr" rid="bib58">Lin et al., 2013</xref>); and UVB injury promotes dendrite growth by decreasing RhoA expression (<xref ref-type="bibr" rid="bib31">Jian et al., 2014</xref>). In all of these studies, RhoA activation was chiefly assayed using techniques that provide no spatial data (<xref ref-type="bibr" rid="bib57">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Iida et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Kranenburg et al., 1999</xref>), so very little is known about the developmental dynamics of RhoA activation. We extended these pioneering results by employing a RhoA knockout model (<xref ref-type="bibr" rid="bib62">Mulherkar et al., 2013</xref>) and by using RhoA-specific FRET probes (<xref ref-type="bibr" rid="bib66">Nakamura et al., 2006</xref>; <xref ref-type="bibr" rid="bib72">Pertz et al., 2006</xref>) to measure authentic RhoA effects and spatiotemporal dynamics. In so doing, we elucidated three previously unknown features of dendritic RhoA signaling: (i) RhoA activation peaks late in development and mediates the transition from dendrite growth to growth arrest; (ii) BAI1 is required to activate RhoA in this context, presumably by transducing some signal and (iii) RhoA activation levels established by 16 DIV determine the ultimate developmental fate of individual persistent dendrites. These results provide a bridge between the expansion of dendritic arbors during development and the requirement for RhoA inhibition to achieve dendrite stability at later time points (<xref ref-type="bibr" rid="bib58">Lin et al., 2013</xref>; <xref ref-type="bibr" rid="bib82">Sfakianos et al., 2007</xref>).</p><p>It is worth noting that some part of our conclusions on RhoA function in BAI1 signaling and dendritic growth arrest entails the use of pharmacological agents to manipulate RhoA signaling. We used narciclasine to activate RhoA late in development. Though narciclasine is effective on RhoA at very low concentrations (<xref ref-type="bibr" rid="bib21">Fürst, 2016</xref>; <xref ref-type="bibr" rid="bib55">Lefranc et al., 2009</xref>; <xref ref-type="bibr" rid="bib101">Van Goietsenoven et al., 2013</xref>), it has other targets, including ef1A (<xref ref-type="bibr" rid="bib21">Fürst, 2016</xref>). Narciclasine has marked cytotoxic effects at concentrations at 1 µM, though at 50 nM it has a cytostatic effect, and this is due to its action on the cytoskeleton though RhoA (<xref ref-type="bibr" rid="bib101">Van Goietsenoven et al., 2013</xref>). We observed effective activation of RhoA at 10 nM, and it had no effect on Rac1 at twice the concentration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). We also acknowledge a lack of specificity of Y-27632 and note that although it inhibits several kinases, it is most effective on those regulated by RhoA (<xref ref-type="bibr" rid="bib11">Davies et al., 2000</xref>). Moreover, since these drugs do not depend on BAI1 and many different signals employ RhoA, it is possible that their effects arise from some parallel pathway. At the concentrations that we use, there was no effect of either drug on the control neurons. We chose these concentrations using the pharmacogenetic strategy of <xref ref-type="bibr" rid="bib91">Stoica et al. (2011)</xref>, in which a subthreshold concentration of drug only acts in synergy with other alterations of the target. Manipulations of BAI1 are the alterations in this case, and the target is RhoA. When considered in the light of the other RhoA-specific techniques presented here, it is thus likely that these drugs mediate their effects by compensating for changes in RhoA signaling caused by BAI1 manipulations.</p><p>Even allowing that BAI1 mediates its effects on arbors through RhoA, a number of interesting questions remain. What are the steps that connect BAI1/RhoA to growth arrest? Is it due to the effects of RhoA-regulated kinases on the actin and/or microtubule cytoskeleton? This might seem to be the most likely, yet Rho-GTPases also regulate gene expression (<xref ref-type="bibr" rid="bib3">Bahrami and Drabløs, 2016</xref>) and there are high levels of RhoA in neuronal somata (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Rho-GTPases also regulate membrane traffic (<xref ref-type="bibr" rid="bib76">Ridley, 2006</xref>), another process relevant to dendrite growth, and any single effect or combination thereof might contribute to BAI1-dependent arbor sculpting.</p><p>In any event, a greater understanding of RhoA signaling in the nervous system is merited, given the role of RhoA in intellectual disabilities (<xref ref-type="bibr" rid="bib65">Nadif Kasri and Van Aelst, 2008</xref>), autism spectrum disorder (<xref ref-type="bibr" rid="bib109">Zunino et al., 2016</xref>), Alzheimer’s disease (<xref ref-type="bibr" rid="bib28">Henderson et al., 2016</xref>; <xref ref-type="bibr" rid="bib97">Tsushima et al., 2015</xref>), Parkinson’s disease (<xref ref-type="bibr" rid="bib48">Labandeira-Garcia et al., 2015</xref>), and Timothy Syndrome (<xref ref-type="bibr" rid="bib42">Krey et al., 2013</xref>), all of which exhibit altered dendritic arbors (<xref ref-type="bibr" rid="bib44">Kulkarni and Firestein, 2012</xref>; <xref ref-type="bibr" rid="bib42">Krey et al., 2013</xref>). Moreover, since RhoA functions as a second messenger and is in many different signaling pathways, it might be safer, more specific, and ultimately more beneficial to target specific RhoA signaling pathways rather than RhoA generally, even if broad-spectrum inhibition of RhoA can, at times, be beneficial (<xref ref-type="bibr" rid="bib64">Mulherkar et al., 2017</xref>).</p></sec><sec id="s3-2"><title>Complexity of BAI1 and A-GPCR signaling</title><p>We previously showed that BAI1 promotes excitatory synaptogenesis by recruiting the Rac1 activator complex Par3/Tiam1 (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). Subsequently, it was demonstrated that BAI1 interacts with the E3 ubiquitin ligase MDM2 to regulate levels of PSD95, an important scaffold in the post-synaptic density, and is required for hippocampal long-term depression (<xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>). BAI1 also activates Rac1 via the ELMO1/DOCK180 activator complex, giving rise to phagocytosis (<xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>), couples to RhoA via Gα<sub>12/13 </sub>(<xref ref-type="bibr" rid="bib89">Stephenson et al., 2013</xref>), functionally interacts with the synaptic organizer NL1, and signals trans-synaptically to promote presynaptic development (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). We now show that BAI1 signals to RhoA through a different mechanism, as demonstrated by the rescue of BAI1 Kd phenotypes by BAI1•∆GPCR (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Thus, BAI1 signals through at least five mechanisms, including two pairs of mechanisms that couple to the same second messengers; those mechanisms coupling to Rac1 lead to different cellular outcomes (i.e., synaptogenesis versus engulfment). BAI1’s signaling role as we have elucidated it in neurons is summarized in <xref ref-type="fig" rid="fig9">Figure 9</xref>. These data paint a picture of BAI1 as a signaling integrator that couples to different signaling pathways as appropriate.</p><fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.47566.057</object-id><label>Figure 9.</label><caption><title>Mechanisms for BAI1’s action promoting axo-dendritic contacts yet inhibiting dendro-dendritic contacts.</title><p>Previous work revealed that BAI1 interacts with PSD95 (<xref ref-type="bibr" rid="bib108">Zhu et al., 2015</xref>) and Tiam1/Par3 by which it activates Rac1, promoting synaptogenesis and spinogenesis (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). Moreover, BAI1 interacts with the synaptic organizer neuroligin 1 (NRLN1) and is required for NRLN1’s ability to promote synaptogenesis (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>) and directs presynaptic differentiation through an unknown mechanism (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>). NRLN1 also interacts with neurexin-1 (NRXN1) and with NMDA receptors via PSD95 (<xref ref-type="bibr" rid="bib61">Mondin et al., 2011</xref>). This study reveals an interaction between BAI1 and Bcr that promotes RhoA activation and restricts overall dendrite growth. Bcr also inhibits Rac1, which opposes RhoA activation in promoting dendrite growth.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47566-fig9-v1.tif"/></fig><p>How does BAI1 ‘choose’ a downstream pathway? An easy model is that a code in the form of combinations of bound ligands may stipulate the events downstream of BAI1. This is especially plausible when one considers that BAI1 has at least eight ligand-binding domains and motifs (<xref ref-type="bibr" rid="bib16">Duman et al., 2016</xref>). Unfortunately, there have been fewer ligands reported for BAI1 than ligand-binding domains, but those include phosphatidylserine (<xref ref-type="bibr" rid="bib70">Park et al., 2007</xref>), bacterial lipopolysaccharide (<xref ref-type="bibr" rid="bib10">Das et al., 2011</xref>), and α<sub>v</sub>ß<sub>5</sub> integrin (<xref ref-type="bibr" rid="bib38">Koh et al., 2004</xref>). Additional BAI1 ligands relevant for neuronal development and function remain to be identified. Moreover, other changes in BAI1 might affect its signaling, including its level, which does appear to increase shortly before and during the process of growth arrest (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). Clearly, a full description of BAI1’s levels, ligands, and signaling outcomes would be helpful for understanding these phenomena.</p></sec><sec id="s3-3"><title>Conclusion</title><p>We identified a new mechanism for restricting dendrite growth that connects the A-GPCR BAI1 to the small GTPase RhoA through Bcr. We provide evidence that directly correlates RhoA activation state to dendrite behavior, and show that BAI1 is required to maintain this relationship. In building on the rapidly growing portraits of A-GPCR function, our results suggest that BAI1 integrates signals and can ‘select’ pathways to mediate differing outcomes. These results might be generalizable to other A-GPCRs, perhaps especially the closely related BAI2/ADGRB2 and BAI3/ADGRB3 (<xref ref-type="bibr" rid="bib84">Shiratsuchi et al., 1997</xref>). However, even by itself, this pathway has great potential significance. Could activation of this dendritic restriction pathway correct dendritic hypertrophy in ASD models and patients? Could inhibition thereof correct hypotrophy in other ASD patients? Is dendrite retraction in neurodegenerative disease caused by hyperactivation of this or other dendritic restriction mechanisms? The answers to these questions will have great significance in addressing the challenges of human mental health.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Gene (<italic>Homo sapiens</italic>)</td><td>ADGRB1</td><td>NA</td><td>Gene ID:575</td><td/></tr><tr><td>Gene (<italic>Rattus norvegicus</italic>)</td><td>ADGRB1</td><td>NA</td><td>Gene ID:362931</td><td/></tr><tr><td>Gene (<italic>H. sapiens</italic>)</td><td>BCR</td><td>NA</td><td>Gene ID:613</td><td/></tr><tr><td>Gene (<italic>Mus musculus)</italic></td><td>BCR</td><td>NA</td><td>Gene ID:110279</td><td/></tr><tr><td>Gene (<italic>M. musculus)</italic></td><td>RHOA</td><td>NA</td><td>Gene ID:11848</td><td/></tr><tr><td>Strain (<italic>M. musculus)</italic></td><td>RhoAflox/flox</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23825607">23825607</ext-link></td><td/><td/></tr><tr><td>Strain (<italic>M. musculus)</italic></td><td>Bcr KO</td><td>Jackson Labs</td><td>Stock no. 026396</td><td/></tr><tr><td>Strain (<italic>R. norvegicus</italic>)</td><td>Long-Evans</td><td>Envigo, Charles River</td><td>HsdBlu:LE (E); Strain 006 (CR); <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/RGD_2308852">RGD_2308852</ext-link></td><td>Timed pregnant females</td></tr><tr><td>Cell line (<italic>Cercopithecus aethiops</italic>)</td><td>Cos-7</td><td>ATCC</td><td>CRL-1651; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0224">CVCL_0224</ext-link></td><td/></tr><tr><td>Antibody</td><td>anti-BAI1 (C-terminal) (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23595754">23595754</ext-link></td><td>2525</td><td>0.001 mg/ml for WB, IHC, ICC; 1 µg/1.3E6 neurons for IP</td></tr><tr><td>Antibody</td><td>anti-BAI1 (N-terminal) (rabbit polyclonal) (H-270)</td><td>Santa Cruz Biotechnology</td><td>Santa Cruz:sc-66815; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2062912">AB_2062912</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>anti-Bcr <break/>(rabbit polyclonal) (N-20)</td><td>Santa Cruz Biotechnology</td><td>Santa Cruz:sc-885; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2274682">AB_2274682</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>anti-Abr <break/>(mouse monoclonal) (<xref ref-type="bibr" rid="bib58">Lin et al., 2013</xref>)</td><td>Santa Cruz Biotechnology</td><td>Santa Cruz:sc-135821; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2221350">AB_2221350</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>anti-c-myc (mouse monoclonal) (9E10)</td><td>Santa Cruz Biotechnology</td><td>Santa Cruz:sc-40;RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_627268">AB_627268</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>anti-BAI2 (extracellular) (rabbit polyclonal)</td><td>Alomone Labs</td><td>Alomone:ABR-022; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2756544">AB_2756544</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>anti-BAI3 (rabbit polyclonal)</td><td>Sigma-Aldrich</td><td>Sigma-Aldrich:HPA015963; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1845263">AB_1845263</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>anti-actin (clone C4) (mouse monoclonal)</td><td>Millipore</td><td>Millipore:MAB1501; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2223041">AB_2223041</ext-link></td><td>(1:10,000)</td></tr><tr><td>Antibody</td><td>Cy3-anti-rabbit secondary</td><td>Jackson ImmunoResearch Laboratories</td><td>Jackson ImmunoResearch:115165003; RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2338000">AB_2338000</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Cy3-anti-mouse secondary</td><td>Jackson ImmunoResearch Laboratories</td><td>Jackson ImmunoResearch:115165146; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2338690">AB_2338690</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>HRP-anti-rabbit secondary</td><td>Millipore</td><td valign="bottom">Millipore:401393; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_437797">AB_437797</ext-link></td><td>(1:20,000)</td></tr><tr><td>Antibody</td><td>HRP-anti-mouse secondary</td><td>Millipore</td><td>Millipore:401215; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10682749">AB_10682749</ext-link></td><td>(1:20,000)</td></tr><tr><td>Recombinant DNA reagent</td><td>pCMV-EGFP</td><td>Connie Cepko</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_11153">Addgene_11153</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.1-mRuby2</td><td>Michael Lin</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_40260">Addgene_40260</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pCx-EGFP</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23595754">23595754</ext-link></td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>pRaichu-Raichu-Rac1</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16472667">16472667</ext-link></td><td>1034X</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pRaichu-Raichu-RhoA</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16472667">16472667</ext-link></td><td>1298X</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pRaichu-Raichu-Rac1-DN</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16472667">16472667</ext-link></td><td>1013X</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pRaichu-Raichu-Rac1-CA</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16472667">16472667</ext-link></td><td>1012X</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pSuper</td><td valign="bottom">Oligoengine</td><td>Oligoengine: VEC-pBS-0002</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/11910072">11910072</ext-link></td></tr><tr><td>Recombinant DNA reagent</td><td>pSuper-shRNA1</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23595754">23595754</ext-link></td><td/><td>5’-GCCCAAATACAGCATCAACA-3’</td></tr><tr><td>Recombinant DNA reagent</td><td>pSuper-shRNA2</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23595754">23595754</ext-link></td><td/><td>5’-CCCGGACCCTCGTCGTTAC-3’</td></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.1-BAI1</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/9533023">9533023</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1-BAI1•∆TEV</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23595754">23595754</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1-BAI1•∆N-term.</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30120207">30120207</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1-BAI1•RKR</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17960134">17960134</ext-link></td><td valign="bottom"/><td valign="bottom">K. Ravichandran (University of Virginia)</td></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1-BAI1•∆GPCR</td><td valign="bottom">this paper</td><td valign="bottom"/><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1-BAI1•∆PRR</td><td valign="bottom">this paper</td><td valign="bottom"/><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pcDNA3.1 (+)</td><td valign="bottom">ThermoFisher Scientific</td><td valign="bottom">ThermoFisher Scientific:V790-20</td><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pCMVmyc-Bcr</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24960694">24960694</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pCMVmyc-Abr</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24960694">24960694</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pCMVmyc-Bcr-GAP-dead</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24960694">24960694</ext-link></td><td valign="bottom">myc-Bcr-GAP-dead</td><td valign="bottom">(R1090A)</td></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pCMVmyc-Bcr-GEF-dead</td><td valign="bottom">this paper</td><td valign="bottom">Myc-Bcr-GEF-dead</td><td valign="bottom">(N689A/E690A) available upon request</td></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pCMV-myc</td><td valign="bottom">Clontech</td><td valign="bottom">Clontech:635689</td><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pGEX-4T1</td><td valign="bottom">Amersham</td><td valign="bottom">Amersham:27458001</td><td valign="bottom"/></tr><tr><td valign="bottom">Recombinant DNA reagent</td><td valign="bottom">pGEX-4T1-BAI1-C-term.</td><td valign="bottom">this paper</td><td valign="bottom"/><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5'-GGAGGGCAGAGGCTGTGAG-3'</td><td valign="bottom">this paper</td><td valign="bottom">BAI1 forward primer</td><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5'-GCAGAGGCTCCAGGGTGAC-3'</td><td valign="bottom">this paper</td><td valign="bottom">BAI1 reverse primer</td><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5’-ATGACCGACTTCGAGAAGGACG-3’</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15225653">15225653</ext-link></td><td valign="bottom">BAI2 forward primer</td><td valign="bottom"/></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5’-CTGCACGTCATCAGCGGAAG-3’</td><td valign="bottom">this paper</td><td valign="bottom">BAI2 reverse primer</td><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Sequence- <break/>based reagent</td><td valign="bottom">5’-TAACCGGCCAGCAGTGTGAAG-3’</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24567399">24567399</ext-link></td><td valign="bottom">BAI3 forward primer</td><td valign="bottom"/></tr><tr><td valign="bottom">Sequence- <break/>based reagent</td><td valign="bottom">5’-CATTCCATCACCTGCCAGCAT C-3’</td><td valign="bottom">this paper</td><td valign="bottom">BAI3 reverse primer</td><td valign="bottom">available upon request from K. Tolias</td></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5’-GATGATATCGCCGCGCTCGTC-3’</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15225653">15225653</ext-link></td><td valign="bottom">actin forward primer</td><td valign="bottom"/></tr><tr><td valign="bottom">Sequence-based reagent</td><td valign="bottom">5’-AGCCAGGTCCAGACGCAGGAT-3’</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15225653">15225653</ext-link></td><td valign="bottom">actin reverse primer</td><td valign="bottom"/></tr><tr><td valign="bottom">Commercial assay or kit</td><td valign="bottom">UltraLink BioSupport</td><td valign="bottom">ThermoFisher Scientific</td><td valign="bottom">ThermoFisher Scientific:53110</td><td valign="bottom"/></tr><tr><td valign="bottom">Chemical compound, drug</td><td valign="bottom">tetradotoxin</td><td valign="bottom">Tocris</td><td valign="bottom">Tocris:1078</td><td valign="bottom"/></tr><tr><td valign="bottom">Chemical compound, drug</td><td valign="bottom">narciclasine</td><td valign="bottom">Tocris</td><td valign="bottom">Tocris:3715/1</td><td valign="bottom"/></tr><tr><td valign="bottom">Chemical compound, drug</td><td valign="bottom">D-AP5</td><td valign="bottom">Tocris</td><td valign="bottom">Tocris:0106/1</td><td valign="bottom"/></tr><tr><td valign="bottom">Chemical compound, drug</td><td valign="bottom">Y-27632 dihydrochloride</td><td valign="bottom">Tocris</td><td valign="bottom">Tocris:TB1254-GMP/10</td><td valign="bottom"/></tr><tr><td valign="bottom">Chemical compound, drug</td><td valign="bottom">Potassium chloride</td><td valign="bottom">ThermoFisher Scientific</td><td valign="bottom">ThermoFisher Scientific:p217</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td valign="bottom">Imaris</td><td valign="bottom">Oxford Instruments</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_007370">SCR_007370</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_007366">SCR_007366</ext-link></td><td valign="bottom">Version 9.2.1</td></tr><tr><td>Software, algorithm</td><td valign="bottom">Fiji</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22743772">22743772</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td valign="bottom">Sholl analysis plugin</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/25264773">25264773</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td valign="bottom">PIXFRET</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16208719">16208719</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td valign="bottom">riFRET</td><td valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/19591240">19591240</ext-link></td><td valign="bottom"/><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td valign="bottom">Zen</td><td valign="bottom">Carl Zeiss. Jena, Germany</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013672">SCR_013672</ext-link></td><td valign="bottom">Version 2.3</td></tr><tr><td>Software, algorithm</td><td valign="bottom">Prism</td><td valign="bottom">Graph Pad</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="bottom">Version 8</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>Neuronal cultures for rats were prepared from Long-Evans rats (Evigo and Charles River, Huntingdon, UK and Wilmington, MA) at E18. For in vivo experiments, in utero electroporation was performed on E14 ICR mice (Charles River). RhoA<sup>flox/flox</sup> and Bcr<sup>KO</sup> mice have already been described (<xref ref-type="bibr" rid="bib62">Mulherkar et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Mulherkar et al., 2014</xref>; <xref ref-type="bibr" rid="bib99">Um et al., 2014</xref>). All animals were maintained in Baylor College of Medicine’s animal facilities, which are fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. All procedures were approved by the Animal Care and Use Committee of BCM (IACUC) in accordance with applicable legislation.</p></sec><sec id="s4-2"><title>DNA Constructs</title><p>pCMV-EGFP was used in mouse and rat cultures for morphological analysis, as we described previously (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). In some experiments we used pcDNA3.1-mRuby2 for morphological analysis, and pCx-EGFP was used to drive expression of EGFP in vivo after in utero electroporation: both were obtained from M. Rasband (Baylor College of Medicine). We used the following FRET-based Rho-GTPase activity reporters: pRaichu-RaichuEV-Rac1 (2248X) (<xref ref-type="bibr" rid="bib39">Komatsu et al., 2011</xref>), pRaichu-RaichuRhoA (1298X) (<xref ref-type="bibr" rid="bib66">Nakamura et al., 2006</xref>), and RhoA-FLARE (<xref ref-type="bibr" rid="bib72">Pertz et al., 2006</xref>). The former two were obtained from M. Matsuda (University of Kyoto) and the last from K. Hahn (University of North Carolina). The two shRNAs against BAI1 used target non-overlapping sequences within the <italic>Adgrb1</italic> sequence subcloned into pSuper (Oligoengine, Seattle, WA) and were described previously (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). The sequences were <named-content content-type="sequence">5’-GCCCAAATACAGCATCAACA-3’</named-content> for shRNA1 (corresponding to bps 4296–4318 in rat <italic>Adgrb1</italic> mRNA) and <named-content content-type="sequence">5’-CCCGGACCCTCGTCGTTAC-3’</named-content> for shRNA2 (corresponding to bps 1116–1134 in rat <italic>Adgrb1</italic> mRNA). tdTomato-Cre was obtained from Edward Boyden. Human BAI1 was obtained from Y. Nakamura (University of Tokyo). We described BAI1•∆TEV (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>) and BAI1•∆N-term. (<xref ref-type="bibr" rid="bib98">Tu et al., 2018</xref>) previously. BAI1•RKR was obtained from K. Ravichandran (University of Virginia). BAI1•∆GPCR and BAI1•∆PRR were produced for this study using standard cloning techniques. The cDNA sequence between the first transmembrane domain of the BAI1-GPCR and the end of the seventh transmembrane domain was removed in the BAI1•∆GPCR mutant. The cDNA encoding residues 1407–1430, a stretch containing 19 prolines in 24 amino acids, was removed in the BAI1•∆PRR. pcDNA3.1 (+) (Invitrogen, Waltham, MA) was the host vector for all BAI1 constructs and was also used to balance DNA amounts in transfections. Myc-Bcr, myc-Abr, and myc-Bcr-GAP-dead (R1090A) were as described previously (<xref ref-type="bibr" rid="bib99">Um et al., 2014</xref>). Myc-Bcr-GEF-dead (N689A/E690A) was created by subcloning the mutated Bcr sequence from ECFP-Bcr NE/AA, obtained from Nora Heisterkamp (Addgene, plasmid #36418) into pCMV-myc. All constructs were sequence verified.</p></sec><sec id="s4-3"><title>Antibodies and drugs</title><p>An anti-BAI1 rabbit polyclonal was generated (Covance, Princeton, NJ) against amino acids 1180–1584 of human BAI1 and affinity purified using the antigen purified as a thrombin-cleaved GST-fusion coupled to UltraLink BioSupport (Thermo Scientific, Waltham, MA). We described this antibody previously (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>); BAI1 is only detected by this antibody in Western blots of Cos-7 cells when they are exogenously expressing BAI1. The immunoreactivity of this antibody for neurons is strongly decreased by BAI1 Kd. This antibody was used at 0.001 mg/ml for IHC, ICC, and Western blotting and was reused at least 5X. For immunoprecipitation, 1 µg per 1.3 × 10<sup>6</sup> neurons in culture was used. Rabbit anti-BAI11 N-terminal polyclonal (H-270, sc-66815), rabbit anti-Bcr polyclonal (N-20, sc-885), mouse anti-Abr monoclonal IgG<sub>1</sub> (24, sc-135821), and mouse monoclonal anti-c-myc IgG<sub>1</sub> (9E10, sc-40) were obtained from Santa Cruz Biotechnology (Dallas, TX) and used at 1:1000 dilution for Westerns and ICC. DMSO (D2650) was obtained from Sigma (St. Louis, MO). Tetradotoxin, narciclasine, D-AP5, and Y-27632 dihydrochloride were obtained from Tocris (Minneapolis, MN). Potassium chloride (P217) was obtained from Fisher Scientific (Pittsburgh, PA).</p></sec><sec id="s4-4"><title>In vivo assessment of BAI1 function</title><p>EGFP and empty or shRNA-containing pSuper was introduced into E14 mice via in utero electroporation as described (<xref ref-type="bibr" rid="bib27">Hedstrom et al., 2007</xref>). Pups were euthanized at P21. Brains were dissected and fixed with 4% paraformaldehyde (Sigma) at 4 °C for 1 hr on ice and equilibrated in ice-cold 20% w/v sucrose (Sigma). 30 µm sections were cut and used for immunostaining in PBS (Corning, Corning, NY) containing 0.3% Triton X-100 (USB, Salem, MA) and 5% BSA (Fisher Scientific). Primary antibodies against BAI1 were applied for 2–3 days and Cy3-labelled goat anti-rabbit IgG (Jackson Immunoresearch, West Grove, PA) was applied for 1 day. Sections were mounted in VectaShield (Vector Laboratories, Burlingame, CA) 100 µm coronal sections were cut from regions containing hippocampus for assessing dendrite arborization. After collecting image stacks with a ∆z of 0.5 µm, dendritic arbors of EGFP-expressing pyramidal neurons from dorsolateral CA1 were reconstructed as below. Only neurons whose cell bodies were centered within 10 µm of the center of the stack z-dimension were analyzed. Reconstruction was limited to single sections because the relatively high local levels of transfection made it impossible to positively assign unassociated dendrites, even in serial sections.</p></sec><sec id="s4-5"><title>Neuronal culture, transfection, and immunostaining</title><p>Rat hippocampal cultures (used in <xref ref-type="fig" rid="fig1">Figures 1i–k</xref>, <xref ref-type="fig" rid="fig2">2</xref>–<xref ref-type="fig" rid="fig6">6</xref>, <xref ref-type="fig" rid="fig7">7d–i</xref> and <xref ref-type="fig" rid="fig8">8d–f</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) were prepared from E18 rats. Hippocampi were dissected out, dissociated with papain, washed with trypsin inhibitor (Sigma) and seeded onto nitric acid-washed #1.5 glass (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3a–c</xref>, <xref ref-type="fig" rid="fig4">4</xref> and <xref ref-type="fig" rid="fig5">5</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="supplementary-material" rid="fig3s2sdata1">Figure 3—figure supplement 2—source data 1</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) or cell culture-treated plastic (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3d–i</xref>, <xref ref-type="fig" rid="fig6">6</xref>, <xref ref-type="fig" rid="fig7">7a–c,d–i</xref> and <xref ref-type="fig" rid="fig8">8d–f</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) coated with 20 µg/ml poly-<sc>d</sc>-lysine (Corning) and 3 µg/ml laminin (Corning) at 3.0 × 10<sup>5</sup> neurons/ml in Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen), 2 mM glutamine (Thermo Scientific), and 100 U/ml penicillin/streptomycin (Thermo Scientific). Culture medium was changed on DIV 1. Mouse hippocampal neurons (<xref ref-type="fig" rid="fig8">Figure 8a–c</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>) were prepared from P0 or P1 pups, genotyped by PCR, plated onto pre-coated one glass coverslips (Corning BioCoat), and cultured in the same medium as above only with Neurobasal A medium (Invitrogen). Neurons were transfected on 7 DIV in early experiments (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3a–c</xref> and <xref ref-type="fig" rid="fig5">5a–b,f–h</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), but on 6 DIV for all other experiments (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3d–i</xref>, <xref ref-type="fig" rid="fig4">4</xref>, <xref ref-type="fig" rid="fig5">5c–e,f–h</xref> and <xref ref-type="fig" rid="fig6">6</xref>–<xref ref-type="fig" rid="fig8">8</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). This difference appeared to matter at early stages, as 7 DIV-transfected BAI1 knockdown (Kd) neurons were the same length as controls on 10 DIV, but 6 DIV-transfected BAI1 Kd neurons were shorter than control neurons at 10 DIV. By 21 DIV, it did not matter whether the neurons had been transfected on 6 or 7 DIV. We utilized a modified calcium phosphate transfection protocol using 1.0 µg total DNA/24-well plate well equivalent as previously (<xref ref-type="bibr" rid="bib15">Duman et al., 2013</xref>). For BAI1 overexpression, 0.2 µg DNA/24-well plate well equivalent was used. Use of higher levels resulted in an apparent dominant negative effect. Mouse cultures were prepared from P0 pups in the same manner as for rats, plated on glass, and transfected on 6 DIV as above. At the indicated times or at the end of longitudinal time courses, cultured neurons were fixed with 4% paraformaldehyde and 20% sucrose and stained in PBS containing 5% BSA, 15% goat serum (Invitrogen), and 0.1% Triton X-100. Cy3-conjugated goat anti-rabbit IgG (Jackson) was used as the secondary antibody.</p></sec><sec id="s4-6"><title>Tissue culture and transfection</title><p>Cos-7 cells were cultured in DMEM (Corning) supplemented with penicillin/streptomycin and 10% fetal bovine serum on cell culture-treated plastic. Cells were passaged with trypsin 1-2X per week. Transfection was by the calcium phosphate method as above for neurons or by LipofectAmine 2000 (ThermoFisher) as per manufacturer’s instructions. A MycoAlert mycoplasma test conducted by the Cell Biology Tissue Culture Core at Baylor College of Medicine confirmed the absence of mycoplasmal infection.</p></sec><sec id="s4-7"><title>Surface staining of BAI1</title><p>Cos-7 cells were transfected with pCMV- EGFP and wild-type human BAI1 or the ∆TEV, RKR, ∆GPCR, or ∆PRR mutants contained in pcDNA3.1(+) using the calcium phosphate technique used for neurons above, the only difference being that the precipitates were not washed off of the cells. One day later, the cells were put on ice and live-stained with 1:500 anti-BAI1 N-terminal polyclonal or anti-BAI1 C-terminal polyclonal in PBS containing 5% BSA for 2 hr. The cells were then washed 4X with ice-cold PBS and fixed with 4% paraformaldehyde and 20% sucrose and washed 3X with PBS. Cells were stained overnight with 1:500 Cy3-conjugated goat anti-rabbit IgG as above. After washing 3X, cells were stained overnight with anti-BAI1 C-terminal antibody and Alexa 568-conjugated goat anti-rabbit IgG as in the neurons above.</p></sec><sec id="s4-8"><title>RNA isolation and real-time RT-PCR</title><p>Total RNA was isolated from DIV 16 rat primary cultures using the Direct-zol TM RNA MiniPrep Plus kit (Zymo R2070) and reverse transcribed using the Quantiscript Reverse Transcriptase and random primers (Qiagen, 205311) following the manufacturers’ protocols. All rtPCR reactions were carried out using GoTaq Green PCR Master Mix (Promega, M7128) and a BioRad C1000 Touch thermocycler with the following conditions: 5 min at 94°C, followed by 40 cycles of 30 s at 94°C, 30 s at 60°C, and 45 s at 72°C, then a final 5 min at 72°C. The amplification products were visualized on 1% agarose gels under UV epifluorescence following ethidium bromide staining. Primers used include <named-content content-type="sequence">5’-ATGACCGACTTCGAGAAGGACG-3’</named-content> (forward) and <named-content content-type="sequence">5’-TCTGCGGCATCTGGTCAATGTG-3’</named-content> (reverse) for BAI1; <named-content content-type="sequence">5’-ATGACCGACTTCGAGAAGGACG-3’</named-content> (forward) and <named-content content-type="sequence">5’-CTGCACGTCATCAGCGGAAG-3’</named-content> (reverse) for BAI2; <named-content content-type="sequence">5’-TAACCGGCCAGCAGTGTGAAG-3’</named-content> (forward) and <named-content content-type="sequence">5’-CATTCCATCACCTGCCAGCAT C-3’</named-content> (reverse) for BAI3; and <named-content content-type="sequence">5’-GATGATATCGCCGCGCTCGTC-3’</named-content> (forward) and <named-content content-type="sequence">5’-AGCCAGGTCCAGACGCAGGAT-3’</named-content> (reverse) for actin. Reverse primers for BAI2 and BAI3 were designed using Snapgene.</p></sec><sec id="s4-9"><title>SDS-PAGE and western blotting</title><p>Cells were lysed in NP40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA, pH 8.0, 5% glycerol) with 1 mM DTT, Complete protease inhibitor mixture (Roche, 4693116001), and XpertPhosphatase Inhibitor Cocktail (GenDEPOT, P3200-001) 10 days after transfection. Proteins were then subjected to SDS-PAGE using 4–15% gradient gels (BioRad, 456–1084), followed by transfer to Immobilon-P (Millipore) PVDF membranes. All western blots were visualized on an ImageQuant LAS4000 (GE Lifesciences).</p></sec><sec id="s4-10"><title>Microscopy</title><p>Three microscopes were used to collect data: a Leica TCS SP2 confocal microscope (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3a–c</xref> and <xref ref-type="fig" rid="fig5">5a–b,f–h</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), a Zeiss AxioObserver.1 attached to an Apotome (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig3">3d–i</xref>, <xref ref-type="fig" rid="fig4">4</xref>, <xref ref-type="fig" rid="fig5">5c–e,f–h</xref>, <xref ref-type="fig" rid="fig6">6</xref>, <xref ref-type="fig" rid="fig7">7j–k</xref> and <xref ref-type="fig" rid="fig8">8a–c</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>), and a Zeiss LSM 880 operating in confocal mode (<xref ref-type="fig" rid="fig7">Figures 7d–f</xref> and <xref ref-type="fig" rid="fig8">8d–f</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Z-stacks (∆z = 1 µm) from sections cut from intact brains (<xref ref-type="fig" rid="fig1">Figure 1</xref>) were imaged with a 63 × oil immersion lens and the pinhole set at one airy. Whole-arbor images of cultured neurons were collected with 10 × objectives, while high magnification images (<xref ref-type="fig" rid="fig5">Figure 5a–e</xref> insets and Supplementary Data 3f-h, 8) employed 63 × objectives and were collected as Z-stacks (∆z = 0.2 µm). Fixed cultures were mounted in FluorSave (EMD Millipore, Burlington, MA). For longitudinal imaging, neurons or Cos-7 cells were switched into 0.2 µm-filtered HEPES-containing 1.5 × ACSF (124 mM NaCl, 3.0 mM KCl, 1.3 mM NaH<sub>2</sub>PO<sub>4</sub>•H<sub>2</sub>O, 3.0 MgCl<sub>2</sub>, 10.0 mM dextrose, 10 mM HEPES (pH 7.4), and 3.0 mM CaCl<sub>2</sub>) (all reagents from Sigma-Aldrich), and a memory stage on the AxioObserver was employed to revisit the same neurons. FRET data collected with Leica employed the following settings: excitation 458 nm, emission 530–600 nm (FRET); excitation 458 nm, emission 470–500 nm (CFP); and excitation 514 nm, emission 530–600 nm (YFP). FRET data was collected with the AxioObserver using the following filter sets: excitation BP 436/20, beamsplitter FT455, emission BP 535/30 (FRET); excitation BP 436/25, beamsplitter FT455, emission BP480/40 (CFP); and excitation BP 500/25, beamsplitter FT515, emission BP 535/30 (YFP). Standard EGFP and Cy3 confocal settings and filter sets were employed when appropriate on all instruments.</p></sec><sec id="s4-11"><title>Data extraction and analysis</title><p>Experimental conditions of samples were blinded to data collectors and analyzers for most experiments. In some longitudinal studies, samples were not blinded but neurons were selected very early in development before any differences between the conditions were apparent (5 DIV). Removal of neurons from these analyses was not allowed with the single exception of neurons that died prior to the end of the time course. For fixed neurons, neurons were excluded if staining indicated very high overexpression of BAI1 or failure of BAI1 Kd. Both exclusions were rare. For dendritic arbors from in vivo hippocampus, z-stacks were used to create 3<sc>D</sc> reconstructions in Imaris 7.1 (Bitplane, Belfast, UK), and for the spine measurements in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>, Imaris 9.1 was used. All data reported in <xref ref-type="fig" rid="fig1">Figure 1</xref> were extracted from these reconstructions. For single-plane reconstructions, we used the NeuronJ plugin of ImageJ (NIH); again, all morphological data were extracted from these models. Sholl analyses were performed using the ImageJ Sholl plugin. BAI1 expression levels in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2H</xref> were extracted from z-stacks using the Spots object function in Imaris, corrected for background. FRET data were analyzed using the PIX-FRET (<xref ref-type="bibr" rid="bib19">Feige et al., 2005</xref>) or RiFRET (<xref ref-type="bibr" rid="bib78">Roszik et al., 2009</xref>) plugins for ImageJ. Absolute FRET images were divided by images of the directly excited acceptor to correct FRET images for differences in probe expression. This was not necessary for images processes with RiFRET. These processed values, restricted to certain regions of interest (ROI) at given times are referred to as <inline-formula><mml:math id="inf1"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in the formulae below. Dendrite tips were defined as the last 1 µm of dendritic shaft. RhoA activation levels in the dendritic tips closely paralleled overall dendritic levels but were easier to extract. Dendrite branch points were defined as the region of the parent dendrite (defined as the dendrite with larger gauge after the branch) normal to the daughter dendrite and equal in depth to the base of the daughter dendrite. This method encompasses the specialized structures, such as Golgi outposts, that reside in dendritic branch points (<xref ref-type="bibr" rid="bib74">Quassollo et al., 2015</xref>). Normalized FRET intensity in various regions of interest was collected as noted. Data were plotted using IgorPro (WaveMetrics, Lake Oswego, OR). The lookup table used to show relative differences in normalized FRET is shown in each relevant figure. To date, no calibration of the FRET probes used in this study has been published. Thus, the differences in FRET indicate a continuum of relative differences, i.e. higher and lower, but the exact numerical relationship between them is unknown. As a result, it was necessary to normalize to points fixed in time and space. For <xref ref-type="fig" rid="fig3">Figures 3a-c</xref>, <xref ref-type="fig" rid="fig6">6</xref>, <xref ref-type="fig" rid="fig7">7j-k</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, the reported FRET values were calculated as:<disp-formula id="equ1"><mml:math id="m1"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>÷</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula>where <inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the final FRET value, <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the processed FRET value in a particular region of interest and <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>S</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the average processed FRET values of all of the control somata at the initial time point. For the data shown in <xref ref-type="fig" rid="fig3">Figure 3e-i</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig5">Figures 5e-g</xref>, <xref ref-type="fig" rid="fig7">7a-c</xref> the reported FRET values were calculated as:<disp-formula id="equ2"><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover><mml:mi>F</mml:mi><mml:mo>−</mml:mo></mml:mover><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>÷</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula><sub>t</sub> are defined as above, and <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mo>.</mml:mo><mml:mo>,</mml:mo> <mml:mi/><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the average processed FRET value of the stable dendrites in control neurons at the initial time point or the whole cell at the start of the experiment for Cos-7 cell experiments. These data are uncalibrated, as are all measurements utilizing Raichu probes or RhoA-FLARE. % differences between measurements reflect normalized % changes, but these may not map linearly to changes in RhoA or Rac1 activation in cells.</p></sec><sec id="s4-12"><title>Collage assembly</title><p>For each collage, all images were taken from the same repeat of the experiment. In <xref ref-type="fig" rid="fig8">Figure 8a</xref>, the displayed images in each row come from the same animal. For the images of somatodendritic domains (<xref ref-type="fig" rid="fig1">Figures 1i</xref>, <xref ref-type="fig" rid="fig2">2a, f</xref>, <xref ref-type="fig" rid="fig3">3a, e–f</xref>, <xref ref-type="fig" rid="fig4">4a, f</xref>, <xref ref-type="fig" rid="fig5">5a–e</xref>, <xref ref-type="fig" rid="fig6">6a</xref>, <xref ref-type="fig" rid="fig7">7d</xref>, <xref ref-type="fig" rid="fig8">8a and d</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) all axons and neurons aside from those chosen were cropped out of the image and the image was thresholded for ease of viewing. In all cases, the same display parameters (background correction, brightness, contrast, gamma) were used for all panels within a collage.</p></sec><sec id="s4-13"><title>Statistical methods</title><p>All data are shown ± s.e.m., except for the insets in <xref ref-type="fig" rid="fig3">Figure 3i</xref> and <xref ref-type="fig" rid="fig7">Figure 7i</xref> in which 95% confidence intervals are shown. Most data sets were initially subjected to ANOVA with the appropriate dimensionality (1-, 2-, or 3-way). If F exceeded F<sub>crit</sub> with a P value of less than 0.05 for any of the tests returned by the ANOVA, we rejected the null hypothesis and proceeded to <italic>post hoc</italic> analysis. Tukey’s <italic>post hoc</italic> analysis was used for pairwise comparisons when appropriate. Normality was assumed for all data sets, and data spot checks confirmed this. In a few cases with only two conditions Student’s T-test (2-tailed) was used. Differences between conditions were considered significant if Tukey’s or Student’s P values were less than 0.05. Data pairs within a single graph may be assumed to be statistically the same unless otherwise noted. In figure legends, <italic>N</italic> refers to the number of biologically independent preparations, i.e. the number of individual timed pregnant rats from which cultures were derived, individual mice, or completely independent cultured cell repeats of an experiment. The numbers of individual cells, dendrites, etc. for each condition (i.e., technical repeats) are reported in the figure legends. The fits in <xref ref-type="fig" rid="fig3">Figure 3i</xref> were obtained via linear regression of automatically binned data. Differences between the slopes of these fits were considered significant if both (i) separation between the values of the slopes exceeded the errors associated with the fitted slopes and (ii) the binned data points from which the slopes were derived showed significant differences across the ∆length continuum. No explicit power analysis was used to determine sample size, but all experiments have at least three independent biological repeats (<italic>N</italic> ≥ 3); many experiments have more than three repeats due to low numbers of individual neurons within one or more conditions within one or more repeats. All statistical analyses were performed in IgorPro, except for 3-factor ANOVAs, which were performed in Prism GraphPad (San Diego, CA).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank M Matsuda (University of Kyoto), K Hahn (University of North Carolina), Y Nakamura (University of Tokyo), K Ravichandran (University of Virginia), and M Rasband (Baylor College of Medicine) for providing DNA constructs. We also thank N Heisterkamp (Children's Hospital Los Angeles) for creating and sharing the Bcr KO mice. We also thank M Taylor, K Firozi, T Munjal, K Um, and B Schwechter for technical assistance. This work was supported by National Institute of Neurological Disorders and Stroke grant R01NS062829 (KFT), National Institute of Mental Health grants R01MH109511 (KFT) and K01MH089112 (JGD), and the Mission Connect-TIRR Foundation (KFT).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Resources, Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Resources, Validation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Methodology, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#AN-4365) of Baylor College of Medicine.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.47566.058</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-47566-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all relevant figures.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alder</surname> <given-names>J</given-names></name><name><surname>Kallman</surname> <given-names>S</given-names></name><name><surname>Palmieri</surname> <given-names>A</given-names></name><name><surname>Khadim</surname> <given-names>F</given-names></name><name><surname>Ayer</surname> <given-names>JJ</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name><name><surname>Tsung</surname> <given-names>K</given-names></name><name><surname>Grinberg</surname> <given-names>I</given-names></name><name><surname>Thakker-Varia</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neuropeptide orphanin FQ inhibits dendritic morphogenesis through activation of RhoA</article-title><source>Developmental Neurobiology</source><volume>73</volume><fpage>769</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1002/dneu.22101</pub-id><pub-id pub-id-type="pmid">23821558</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsina</surname> <given-names>FC</given-names></name><name><surname>Hita</surname> <given-names>FJ</given-names></name><name><surname>Fontanet</surname> <given-names>PA</given-names></name><name><surname>Irala</surname> <given-names>D</given-names></name><name><surname>Hedman</surname> <given-names>H</given-names></name><name><surname>Ledda</surname> <given-names>F</given-names></name><name><surname>Paratcha</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lrig1 is a cell-intrinsic modulator of hippocampal dendrite complexity and BDNF signaling</article-title><source>EMBO Reports</source><volume>17</volume><fpage>601</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.15252/embr.201541218</pub-id><pub-id pub-id-type="pmid">26935556</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahrami</surname> <given-names>S</given-names></name><name><surname>Drabløs</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gene regulation in the immediate-early response process</article-title><source>Advances in Biological Regulation</source><volume>62</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jbior.2016.05.001</pub-id><pub-id pub-id-type="pmid">27220739</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname> <given-names>M</given-names></name><name><surname>Jung</surname> <given-names>SY</given-names></name><name><surname>Shaw</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Wong</surname> <given-names>ST</given-names></name><name><surname>Qin</surname> <given-names>J</given-names></name><name><surname>Zoghbi</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription</article-title><source>Science</source><volume>320</volume><fpage>1224</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1126/science.1153252</pub-id><pub-id pub-id-type="pmid">18511691</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Firestein</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RhoA regulates dendrite branching in hippocampal neurons by decreasing cypin protein levels</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>8378</fpage><lpage>8386</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0872-07.2007</pub-id><pub-id pub-id-type="pmid">17670984</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>N</given-names></name><name><surname>Alshammari</surname> <given-names>F</given-names></name><name><surname>Hughes</surname> <given-names>E</given-names></name><name><surname>Khanbabaei</surname> <given-names>M</given-names></name><name><surname>Rho</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0179409</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179409</pub-id><pub-id pub-id-type="pmid">28609458</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copf</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Impairments in dendrite morphogenesis as etiology for neurodevelopmental disorders and implications for therapeutic treatments</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>68</volume><fpage>946</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.04.008</pub-id><pub-id pub-id-type="pmid">27143622</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname> <given-names>MM</given-names></name><name><surname>Sandman</surname> <given-names>CA</given-names></name><name><surname>Poggi Davis</surname> <given-names>E</given-names></name><name><surname>Glynn</surname> <given-names>LM</given-names></name><name><surname>Baram</surname> <given-names>TZ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Abnormal dendritic maturation of developing cortical neurons exposed to corticotropin releasing hormone (CRH): Insights into effects of prenatal adversity?</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0180311</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0180311</pub-id><pub-id pub-id-type="pmid">28658297</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname> <given-names>R</given-names></name><name><surname>Hines</surname> <given-names>RM</given-names></name><name><surname>Eadie</surname> <given-names>BD</given-names></name><name><surname>Kannangara</surname> <given-names>TS</given-names></name><name><surname>Hines</surname> <given-names>DJ</given-names></name><name><surname>Brown</surname> <given-names>CE</given-names></name><name><surname>Christie</surname> <given-names>BR</given-names></name><name><surname>El-Husseini</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the Hippocampus</article-title><source>Hippocampus</source><volume>20</volume><fpage>305</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1002/hipo.20630</pub-id><pub-id pub-id-type="pmid">19437420</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Owen</surname> <given-names>KA</given-names></name><name><surname>Ly</surname> <given-names>KT</given-names></name><name><surname>Park</surname> <given-names>D</given-names></name><name><surname>Black</surname> <given-names>SG</given-names></name><name><surname>Wilson</surname> <given-names>JM</given-names></name><name><surname>Sifri</surname> <given-names>CD</given-names></name><name><surname>Ravichandran</surname> <given-names>KS</given-names></name><name><surname>Ernst</surname> <given-names>PB</given-names></name><name><surname>Casanova</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative Bacteria</article-title><source>PNAS</source><volume>108</volume><fpage>2136</fpage><lpage>2141</lpage><pub-id pub-id-type="doi">10.1073/pnas.1014775108</pub-id><pub-id pub-id-type="pmid">21245295</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>SP</given-names></name><name><surname>Reddy</surname> <given-names>H</given-names></name><name><surname>Caivano</surname> <given-names>M</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Specificity and mechanism of action of some commonly used protein kinase inhibitors</article-title><source>Biochemical Journal</source><volume>351</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1042/bj3510095</pub-id><pub-id pub-id-type="pmid">10998351</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Flores</surname> <given-names>R</given-names></name><name><surname>La Joie</surname> <given-names>R</given-names></name><name><surname>Chételat</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease</article-title><source>Neuroscience</source><volume>309</volume><fpage>29</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.08.033</pub-id><pub-id pub-id-type="pmid">26306871</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name><name><surname>Bülow</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Intrinsic and extrinsic mechanisms of dendritic morphogenesis</article-title><source>Annual Review of Physiology</source><volume>77</volume><fpage>271</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071746</pub-id><pub-id pub-id-type="pmid">25386991</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubash</surname> <given-names>AD</given-names></name><name><surname>Koetsier</surname> <given-names>JL</given-names></name><name><surname>Amargo</surname> <given-names>EV</given-names></name><name><surname>Najor</surname> <given-names>NA</given-names></name><name><surname>Harmon</surname> <given-names>RM</given-names></name><name><surname>Green</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The GEF bcr activates RhoA/MAL signaling to promote keratinocyte differentiation via desmoglein-1</article-title><source>The Journal of Cell Biology</source><volume>202</volume><fpage>653</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1083/jcb.201304133</pub-id><pub-id pub-id-type="pmid">23940119</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname> <given-names>JG</given-names></name><name><surname>Tzeng</surname> <given-names>CP</given-names></name><name><surname>Tu</surname> <given-names>YK</given-names></name><name><surname>Munjal</surname> <given-names>T</given-names></name><name><surname>Schwechter</surname> <given-names>B</given-names></name><name><surname>Ho</surname> <given-names>TS</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>6964</fpage><lpage>6978</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3978-12.2013</pub-id><pub-id pub-id-type="pmid">23595754</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname> <given-names>JG</given-names></name><name><surname>Tu</surname> <given-names>Y-K</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Emerging roles of BAI Adhesion-GPCRs in synapse development and plasticity</article-title><source>Neural Plasticity</source><volume>2016</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2016/8301737</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>MR</given-names></name><name><surname>Zheng</surname> <given-names>S</given-names></name><name><surname>Park</surname> <given-names>D</given-names></name><name><surname>Woodson</surname> <given-names>RI</given-names></name><name><surname>Reardon</surname> <given-names>MA</given-names></name><name><surname>Juncadella</surname> <given-names>IJ</given-names></name><name><surname>Kinchen</surname> <given-names>JM</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Lysiak</surname> <given-names>JJ</given-names></name><name><surname>Ravichandran</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo</article-title><source>Nature</source><volume>467</volume><fpage>333</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/nature09356</pub-id><pub-id pub-id-type="pmid">20844538</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evers</surname> <given-names>EE</given-names></name><name><surname>Zondag</surname> <given-names>GC</given-names></name><name><surname>Malliri</surname> <given-names>A</given-names></name><name><surname>Price</surname> <given-names>LS</given-names></name><name><surname>ten Klooster</surname> <given-names>JP</given-names></name><name><surname>van der Kammen</surname> <given-names>RA</given-names></name><name><surname>Collard</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rho family proteins in cell adhesion and cell migration</article-title><source>European Journal of Cancer</source><volume>36</volume><fpage>1269</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1016/S0959-8049(00)00091-5</pub-id><pub-id pub-id-type="pmid">10882865</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname> <given-names>JN</given-names></name><name><surname>Sage</surname> <given-names>D</given-names></name><name><surname>Wahli</surname> <given-names>W</given-names></name><name><surname>Desvergne</surname> <given-names>B</given-names></name><name><surname>Gelman</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs</article-title><source>Microscopy Research and Technique</source><volume>68</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/jemt.20215</pub-id><pub-id pub-id-type="pmid">16208719</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fombonne</surname> <given-names>E</given-names></name><name><surname>Rogé</surname> <given-names>B</given-names></name><name><surname>Claverie</surname> <given-names>J</given-names></name><name><surname>Courty</surname> <given-names>S</given-names></name><name><surname>Frémolle</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Microcephaly and macrocephaly in autism</article-title><source>Journal of Autism and Developmental Disorders</source><volume>29</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">10382131</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fürst</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Narciclasine - an Amaryllidaceae alkaloid with potent antitumor and Anti-Inflammatory properties</article-title><source>Planta Medica</source><volume>82</volume><fpage>1389</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1055/s-0042-115034</pub-id><pub-id pub-id-type="pmid">27542176</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghiretti</surname> <given-names>AE</given-names></name><name><surname>Kenny</surname> <given-names>K</given-names></name><name><surname>Marr</surname> <given-names>MT</given-names></name><name><surname>Paradis</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CaMKII-dependent phosphorylation of the GTPase Rem2 is required to restrict dendritic complexity</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>6504</fpage><lpage>6515</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3861-12.2013</pub-id><pub-id pub-id-type="pmid">23575848</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grienberger</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Konnerth</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dendritic function in vivo</article-title><source>Trends in Neurosciences</source><volume>38</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2014.11.002</pub-id><pub-id pub-id-type="pmid">25432423</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname> <given-names>J</given-names></name><name><surname>Aust</surname> <given-names>G</given-names></name><name><surname>Araç</surname> <given-names>D</given-names></name><name><surname>Engel</surname> <given-names>FB</given-names></name><name><surname>Formstone</surname> <given-names>C</given-names></name><name><surname>Fredriksson</surname> <given-names>R</given-names></name><name><surname>Hall</surname> <given-names>RA</given-names></name><name><surname>Harty</surname> <given-names>BL</given-names></name><name><surname>Kirchhoff</surname> <given-names>C</given-names></name><name><surname>Knapp</surname> <given-names>B</given-names></name><name><surname>Krishnan</surname> <given-names>A</given-names></name><name><surname>Liebscher</surname> <given-names>I</given-names></name><name><surname>Lin</surname> <given-names>HH</given-names></name><name><surname>Martinelli</surname> <given-names>DC</given-names></name><name><surname>Monk</surname> <given-names>KR</given-names></name><name><surname>Peeters</surname> <given-names>MC</given-names></name><name><surname>Piao</surname> <given-names>X</given-names></name><name><surname>Prömel</surname> <given-names>S</given-names></name><name><surname>Schöneberg</surname> <given-names>T</given-names></name><name><surname>Schwartz</surname> <given-names>TW</given-names></name><name><surname>Singer</surname> <given-names>K</given-names></name><name><surname>Stacey</surname> <given-names>M</given-names></name><name><surname>Ushkaryov</surname> <given-names>YA</given-names></name><name><surname>Vallon</surname> <given-names>M</given-names></name><name><surname>Wolfrum</surname> <given-names>U</given-names></name><name><surname>Wright</surname> <given-names>MW</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Langenhan</surname> <given-names>T</given-names></name><name><surname>Schiöth</surname> <given-names>HB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>International union of basic and clinical pharmacology. XCIV. Adhesion G protein-coupled receptors</article-title><source>Pharmacological Reviews</source><volume>67</volume><fpage>338</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1124/pr.114.009647</pub-id><pub-id pub-id-type="pmid">25713288</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>K</given-names></name><name><surname>Spacek</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><chapter-title>Dendrite structure</chapter-title><person-group person-group-type="editor"><name><surname>Stuart</surname> <given-names>G</given-names></name><name><surname>Spruston</surname> <given-names>N</given-names></name><name><surname>Häusser</surname> <given-names>M</given-names></name></person-group><source>Dendrites</source><publisher-loc>Oxford, United Kingdom</publisher-loc><publisher-name>Oxford University Press</publisher-name><fpage>1</fpage><lpage>46</lpage></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Häusser</surname> <given-names>M</given-names></name><name><surname>Mel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dendrites: bug or feature?</article-title><source>Current Opinion in Neurobiology</source><volume>13</volume><fpage>372</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/S0959-4388(03)00075-8</pub-id><pub-id pub-id-type="pmid">12850223</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedstrom</surname> <given-names>KL</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Ogawa</surname> <given-names>Y</given-names></name><name><surname>Frischknecht</surname> <given-names>R</given-names></name><name><surname>Seidenbecher</surname> <given-names>CI</given-names></name><name><surname>Shrager</surname> <given-names>P</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Neurofascin assembles a specialized extracellular matrix at the axon initial segment</article-title><source>The Journal of Cell Biology</source><volume>178</volume><fpage>875</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1083/jcb.200705119</pub-id><pub-id pub-id-type="pmid">17709431</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname> <given-names>BW</given-names></name><name><surname>Gentry</surname> <given-names>EG</given-names></name><name><surname>Rush</surname> <given-names>T</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Thambisetty</surname> <given-names>M</given-names></name><name><surname>Montine</surname> <given-names>TJ</given-names></name><name><surname>Herskowitz</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain</article-title><source>Journal of Neurochemistry</source><volume>138</volume><fpage>525</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1111/jnc.13688</pub-id><pub-id pub-id-type="pmid">27246255</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henze</surname> <given-names>DA</given-names></name><name><surname>Cameron</surname> <given-names>WE</given-names></name><name><surname>Barrionuevo</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Dendritic morphology and its effects on the amplitude and rise-time of synaptic signals in hippocampal CA3 pyramidal cells</article-title><source>The Journal of Comparative Neurology</source><volume>369</volume><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19960603)369:3&lt;331::AID-CNE1&gt;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">8743416</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iida</surname> <given-names>J</given-names></name><name><surname>Ishizaki</surname> <given-names>H</given-names></name><name><surname>Okamoto-Tanaka</surname> <given-names>M</given-names></name><name><surname>Kawata</surname> <given-names>A</given-names></name><name><surname>Sumita</surname> <given-names>K</given-names></name><name><surname>Ohgake</surname> <given-names>S</given-names></name><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Yorifuji</surname> <given-names>H</given-names></name><name><surname>Nukina</surname> <given-names>N</given-names></name><name><surname>Ohashi</surname> <given-names>K</given-names></name><name><surname>Mizuno</surname> <given-names>K</given-names></name><name><surname>Tsutsumi</surname> <given-names>T</given-names></name><name><surname>Mizoguchi</surname> <given-names>A</given-names></name><name><surname>Miyoshi</surname> <given-names>J</given-names></name><name><surname>Takai</surname> <given-names>Y</given-names></name><name><surname>Hata</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Synaptic scaffolding molecule alpha is a scaffold to mediate N-methyl-D-aspartate receptor-dependent RhoA activation in dendrites</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>4388</fpage><lpage>4405</lpage><pub-id pub-id-type="doi">10.1128/MCB.01901-06</pub-id><pub-id pub-id-type="pmid">17438139</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname> <given-names>Q</given-names></name><name><surname>An</surname> <given-names>Q</given-names></name><name><surname>Zhu</surname> <given-names>D</given-names></name><name><surname>Hui</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Chi</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNA 340 is involved in UVB-induced dendrite formation through the regulation of RhoA expression in melanocytes</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>3407</fpage><lpage>3420</lpage><pub-id pub-id-type="doi">10.1128/MCB.00106-14</pub-id><pub-id pub-id-type="pmid">24980435</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>J</given-names></name><name><surname>Park</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IRSp53/BAIAP2 in dendritic spine development, NMDA receptor regulation, and psychiatric disorders</article-title><source>Neuropharmacology</source><volume>100</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.06.019</pub-id><pub-id pub-id-type="pmid">26275848</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karbowski</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cortical composition hierarchy driven by spine proportion economical maximization or wire volume minimization</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004532</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004532</pub-id><pub-id pub-id-type="pmid">26436731</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasthuri</surname> <given-names>N</given-names></name><name><surname>Hayworth</surname> <given-names>KJ</given-names></name><name><surname>Berger</surname> <given-names>DR</given-names></name><name><surname>Schalek</surname> <given-names>RL</given-names></name><name><surname>Conchello</surname> <given-names>JA</given-names></name><name><surname>Knowles-Barley</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>D</given-names></name><name><surname>Vázquez-Reina</surname> <given-names>A</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Jones</surname> <given-names>TR</given-names></name><name><surname>Roberts</surname> <given-names>M</given-names></name><name><surname>Morgan</surname> <given-names>JL</given-names></name><name><surname>Tapia</surname> <given-names>JC</given-names></name><name><surname>Seung</surname> <given-names>HS</given-names></name><name><surname>Roncal</surname> <given-names>WG</given-names></name><name><surname>Vogelstein</surname> <given-names>JT</given-names></name><name><surname>Burns</surname> <given-names>R</given-names></name><name><surname>Sussman</surname> <given-names>DL</given-names></name><name><surname>Priebe</surname> <given-names>CE</given-names></name><name><surname>Pfister</surname> <given-names>H</given-names></name><name><surname>Lichtman</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Saturated reconstruction of a volume of neocortex</article-title><source>Cell</source><volume>162</volume><fpage>648</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.06.054</pub-id><pub-id pub-id-type="pmid">26232230</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>B</given-names></name><name><surname>Brat</surname> <given-names>DJ</given-names></name><name><surname>Devi</surname> <given-names>NS</given-names></name><name><surname>Van Meir</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor</article-title><source>Oncogene</source><volume>24</volume><fpage>3632</fpage><lpage>3642</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1208317</pub-id><pub-id pub-id-type="pmid">15782143</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerrisk</surname> <given-names>ME</given-names></name><name><surname>Greer</surname> <given-names>CA</given-names></name><name><surname>Koleske</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Integrin α3 is required for late postnatal stability of dendrite arbors, dendritic spines and synapses, and mouse behavior</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>6742</fpage><lpage>6752</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0528-13.2013</pub-id><pub-id pub-id-type="pmid">23595732</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>SJ</given-names></name><name><surname>Wan</surname> <given-names>Q</given-names></name><name><surname>Cho</surname> <given-names>E</given-names></name><name><surname>Han</surname> <given-names>B</given-names></name><name><surname>Yoder</surname> <given-names>MC</given-names></name><name><surname>Voytik-Harbin</surname> <given-names>SL</given-names></name><name><surname>Na</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Matrix rigidity regulates spatiotemporal dynamics of Cdc42 activity and vacuole formation kinetics of endothelial colony forming cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>443</volume><fpage>1280</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.12.135</pub-id><pub-id pub-id-type="pmid">24393843</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>JT</given-names></name><name><surname>Kook</surname> <given-names>H</given-names></name><name><surname>Kee</surname> <given-names>HJ</given-names></name><name><surname>Seo</surname> <given-names>YW</given-names></name><name><surname>Jeong</surname> <given-names>BC</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Kim</surname> <given-names>MY</given-names></name><name><surname>Yoon</surname> <given-names>KC</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>KK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin</article-title><source>Experimental Cell Research</source><volume>294</volume><fpage>172</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2003.11.008</pub-id><pub-id pub-id-type="pmid">14980512</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname> <given-names>N</given-names></name><name><surname>Aoki</surname> <given-names>K</given-names></name><name><surname>Yamada</surname> <given-names>M</given-names></name><name><surname>Yukinaga</surname> <given-names>H</given-names></name><name><surname>Fujita</surname> <given-names>Y</given-names></name><name><surname>Kamioka</surname> <given-names>Y</given-names></name><name><surname>Matsuda</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Development of an optimized backbone of FRET biosensors for kinases and GTPases</article-title><source>Molecular Biology of the Cell</source><volume>22</volume><fpage>4647</fpage><lpage>4656</lpage><pub-id pub-id-type="doi">10.1091/mbc.e11-01-0072</pub-id><pub-id pub-id-type="pmid">21976697</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konopka</surname> <given-names>A</given-names></name><name><surname>Zeug</surname> <given-names>A</given-names></name><name><surname>Skupien</surname> <given-names>A</given-names></name><name><surname>Kaza</surname> <given-names>B</given-names></name><name><surname>Mueller</surname> <given-names>F</given-names></name><name><surname>Chwedorowicz</surname> <given-names>A</given-names></name><name><surname>Ponimaskin</surname> <given-names>E</given-names></name><name><surname>Wilczynski</surname> <given-names>GM</given-names></name><name><surname>Dzwonek</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cleavage of hyaluronan and CD44 adhesion molecule regulate astrocyte morphology via Rac1 signalling</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0155053</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0155053</pub-id><pub-id pub-id-type="pmid">27163367</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranenburg</surname> <given-names>O</given-names></name><name><surname>Poland</surname> <given-names>M</given-names></name><name><surname>van Horck</surname> <given-names>FP</given-names></name><name><surname>Drechsel</surname> <given-names>D</given-names></name><name><surname>Hall</surname> <given-names>A</given-names></name><name><surname>Moolenaar</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activation of RhoA by lysophosphatidic acid and Galpha<sub>12/13</sub> subunits in neuronal cells: induction of neurite retraction</article-title><source>Molecular Biology of the Cell</source><volume>10</volume><fpage>1851</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1091/mbc.10.6.1851</pub-id><pub-id pub-id-type="pmid">10359601</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krey</surname> <given-names>JF</given-names></name><name><surname>Paşca</surname> <given-names>SP</given-names></name><name><surname>Shcheglovitov</surname> <given-names>A</given-names></name><name><surname>Yazawa</surname> <given-names>M</given-names></name><name><surname>Schwemberger</surname> <given-names>R</given-names></name><name><surname>Rasmusson</surname> <given-names>R</given-names></name><name><surname>Dolmetsch</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1038/nn.3307</pub-id><pub-id pub-id-type="pmid">23313911</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krug</surname> <given-names>AK</given-names></name><name><surname>Balmer</surname> <given-names>NV</given-names></name><name><surname>Matt</surname> <given-names>F</given-names></name><name><surname>Schönenberger</surname> <given-names>F</given-names></name><name><surname>Merhof</surname> <given-names>D</given-names></name><name><surname>Leist</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants</article-title><source>Archives of Toxicology</source><volume>87</volume><fpage>2215</fpage><lpage>2231</lpage><pub-id pub-id-type="doi">10.1007/s00204-013-1072-y</pub-id><pub-id pub-id-type="pmid">23670202</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname> <given-names>VA</given-names></name><name><surname>Firestein</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The dendritic tree and brain disorders</article-title><source>Molecular and Cellular Neuroscience</source><volume>50</volume><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2012.03.005</pub-id><pub-id pub-id-type="pmid">22465229</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kweon</surname> <given-names>JH</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The cellular basis of dendrite pathology in neurodegenerative diseases</article-title><source>BMB Reports</source><volume>50</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2017.50.1.131</pub-id><pub-id pub-id-type="pmid">27502014</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>CH</given-names></name><name><surname>Luikart</surname> <given-names>BW</given-names></name><name><surname>Powell</surname> <given-names>CM</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Matheny</surname> <given-names>SA</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Baker</surname> <given-names>SJ</given-names></name><name><surname>Parada</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Pten regulates neuronal arborization and social interaction in mice</article-title><source>Neuron</source><volume>50</volume><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id><pub-id pub-id-type="pmid">16675393</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>HB</given-names></name><name><surname>Kozorovitskiy</surname> <given-names>Y</given-names></name><name><surname>Oh</surname> <given-names>WJ</given-names></name><name><surname>Peixoto</surname> <given-names>RT</given-names></name><name><surname>Akhtar</surname> <given-names>N</given-names></name><name><surname>Saulnier</surname> <given-names>JL</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name><name><surname>Sabatini</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>1667</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1038/nn.3256</pub-id><pub-id pub-id-type="pmid">23143522</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labandeira-Garcia</surname> <given-names>JL</given-names></name><name><surname>Rodríguez-Perez</surname> <given-names>AI</given-names></name><name><surname>Villar-Cheda</surname> <given-names>B</given-names></name><name><surname>Borrajo</surname> <given-names>A</given-names></name><name><surname>Dominguez-Meijide</surname> <given-names>A</given-names></name><name><surname>Guerra</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rho kinase and dopaminergic degeneration: a promising therapeutic target for parkinson's Disease</article-title><source>The Neuroscientist : A Review Journal Bringing Neurobiology, Neurology and Psychiatry</source><volume>21</volume><fpage>616</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1177/1073858414554954</pub-id><pub-id pub-id-type="pmid">25323761</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lainhart</surname> <given-names>JE</given-names></name><name><surname>Piven</surname> <given-names>J</given-names></name><name><surname>Wzorek</surname> <given-names>M</given-names></name><name><surname>Landa</surname> <given-names>R</given-names></name><name><surname>Santangelo</surname> <given-names>SL</given-names></name><name><surname>Coon</surname> <given-names>H</given-names></name><name><surname>Folstein</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Macrocephaly in children and adults with autism</article-title><source>Journal of the American Academy of Child &amp; Adolescent Psychiatry</source><volume>36</volume><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1097/00004583-199702000-00019</pub-id><pub-id pub-id-type="pmid">9031582</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landgraf</surname> <given-names>M</given-names></name><name><surname>Evers</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Control of dendritic diversity</article-title><source>Current Opinion in Cell Biology</source><volume>17</volume><fpage>690</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2005.09.005</pub-id><pub-id pub-id-type="pmid">16226445</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenhan</surname> <given-names>T</given-names></name><name><surname>Aust</surname> <given-names>G</given-names></name><name><surname>Hamann</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sticky signaling--adhesion class G protein-coupled receptors take the stage</article-title><source>Science Signaling</source><volume>6</volume><elocation-id>re3</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2003825</pub-id><pub-id pub-id-type="pmid">23695165</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T</given-names></name><name><surname>Winter</surname> <given-names>C</given-names></name><name><surname>Marticke</surname> <given-names>SS</given-names></name><name><surname>Lee</surname> <given-names>A</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis</article-title><source>Neuron</source><volume>25</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80896-X</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JJ</given-names></name><name><surname>Wedow</surname> <given-names>R</given-names></name><name><surname>Okbay</surname> <given-names>A</given-names></name><name><surname>Kong</surname> <given-names>E</given-names></name><name><surname>Maghzian</surname> <given-names>O</given-names></name><name><surname>Zacher</surname> <given-names>M</given-names></name><name><surname>Nguyen-Viet</surname> <given-names>TA</given-names></name><name><surname>Bowers</surname> <given-names>P</given-names></name><name><surname>Sidorenko</surname> <given-names>J</given-names></name><name><surname>Karlsson Linnér</surname> <given-names>R</given-names></name><name><surname>Fontana</surname> <given-names>MA</given-names></name><name><surname>Kundu</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Royer</surname> <given-names>R</given-names></name><name><surname>Timshel</surname> <given-names>PN</given-names></name><name><surname>Walters</surname> <given-names>RK</given-names></name><name><surname>Willoughby</surname> <given-names>EA</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Alver</surname> <given-names>M</given-names></name><name><surname>Bao</surname> <given-names>Y</given-names></name><name><surname>Clark</surname> <given-names>DW</given-names></name><name><surname>Day</surname> <given-names>FR</given-names></name><name><surname>Furlotte</surname> <given-names>NA</given-names></name><name><surname>Joshi</surname> <given-names>PK</given-names></name><name><surname>Kemper</surname> <given-names>KE</given-names></name><name><surname>Kleinman</surname> <given-names>A</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Mägi</surname> <given-names>R</given-names></name><name><surname>Trampush</surname> <given-names>JW</given-names></name><name><surname>Verma</surname> <given-names>SS</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Lam</surname> <given-names>M</given-names></name><name><surname>Zhao</surname> <given-names>JH</given-names></name><name><surname>Zheng</surname> <given-names>Z</given-names></name><name><surname>Boardman</surname> <given-names>JD</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Freese</surname> <given-names>J</given-names></name><name><surname>Harris</surname> <given-names>KM</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>Herd</surname> <given-names>P</given-names></name><name><surname>Kumari</surname> <given-names>M</given-names></name><name><surname>Lencz</surname> <given-names>T</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Malhotra</surname> <given-names>AK</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Milani</surname> <given-names>L</given-names></name><name><surname>Ong</surname> <given-names>KK</given-names></name><name><surname>Perry</surname> <given-names>JRB</given-names></name><name><surname>Porteous</surname> <given-names>DJ</given-names></name><name><surname>Ritchie</surname> <given-names>MD</given-names></name><name><surname>Smart</surname> <given-names>MC</given-names></name><name><surname>Smith</surname> <given-names>BH</given-names></name><name><surname>Tung</surname> <given-names>JY</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Beauchamp</surname> <given-names>JP</given-names></name><name><surname>Conley</surname> <given-names>DC</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Lehrer</surname> <given-names>SF</given-names></name><name><surname>Magnusson</surname> <given-names>PKE</given-names></name><name><surname>Oskarsson</surname> <given-names>S</given-names></name><name><surname>Pers</surname> <given-names>TH</given-names></name><name><surname>Robinson</surname> <given-names>MR</given-names></name><name><surname>Thom</surname> <given-names>K</given-names></name><name><surname>Watson</surname> <given-names>C</given-names></name><name><surname>Chabris</surname> <given-names>CF</given-names></name><name><surname>Meyer</surname> <given-names>MN</given-names></name><name><surname>Laibson</surname> <given-names>DI</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Johannesson</surname> <given-names>M</given-names></name><name><surname>Koellinger</surname> <given-names>PD</given-names></name><name><surname>Turley</surname> <given-names>P</given-names></name><name><surname>Visscher</surname> <given-names>PM</given-names></name><name><surname>Benjamin</surname> <given-names>DJ</given-names></name><name><surname>Cesarini</surname> <given-names>D</given-names></name><collab>23andMe Research Team</collab><collab>COGENT (Cognitive Genomics Consortium)</collab><collab>Social Science Genetic Association Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1112</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0147-3</pub-id><pub-id pub-id-type="pmid">30038396</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefebvre</surname> <given-names>JL</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Kay</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Development of dendritic form and function</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>31</volume><fpage>741</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013020</pub-id><pub-id pub-id-type="pmid">26422333</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname> <given-names>F</given-names></name><name><surname>Sauvage</surname> <given-names>S</given-names></name><name><surname>Van Goietsenoven</surname> <given-names>G</given-names></name><name><surname>Mégalizzi</surname> <given-names>V</given-names></name><name><surname>Lamoral-Theys</surname> <given-names>D</given-names></name><name><surname>Debeir</surname> <given-names>O</given-names></name><name><surname>Spiegl-Kreinecker</surname> <given-names>S</given-names></name><name><surname>Berger</surname> <given-names>W</given-names></name><name><surname>Mathieu</surname> <given-names>V</given-names></name><name><surname>Decaestecker</surname> <given-names>C</given-names></name><name><surname>Kiss</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Narciclasine, a plant growth modulator, activates rho and stress fibers in glioblastoma cells</article-title><source>Molecular Cancer Therapeutics</source><volume>8</volume><fpage>1739</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-08-0932</pub-id><pub-id pub-id-type="pmid">19531573</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Van Aelst</surname> <given-names>L</given-names></name><name><surname>Cline</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rho GTPases regulate distinct aspects of dendritic arbor growth in xenopus central neurons in vivo</article-title><source>Nature Neuroscience</source><volume>3</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/72920</pub-id><pub-id pub-id-type="pmid">10700252</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Gu</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Xie</surname> <given-names>M</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Xue</surname> <given-names>J</given-names></name><name><surname>Guo</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activation of dopamine D1 receptors regulates dendritic morphogenesis through Rac1 and RhoA in prefrontal cortex neurons</article-title><source>Molecular Neurobiology</source><volume>51</volume><fpage>1024</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1007/s12035-014-8762-1</pub-id><pub-id pub-id-type="pmid">24915967</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>YC</given-names></name><name><surname>Yeckel</surname> <given-names>MF</given-names></name><name><surname>Koleske</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Abl2/Arg controls dendritic spine and dendrite arbor stability via distinct cytoskeletal control pathways</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>1846</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4284-12.2013</pub-id><pub-id pub-id-type="pmid">23365224</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname> <given-names>M</given-names></name><name><surname>Häusser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dendritic computation</article-title><source>Annual Review of Neuroscience</source><volume>28</volume><fpage>503</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.28.061604.135703</pub-id><pub-id pub-id-type="pmid">16033324</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelson</surname> <given-names>JJ</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Gujral</surname> <given-names>M</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Malhotra</surname> <given-names>D</given-names></name><name><surname>Jin</surname> <given-names>X</given-names></name><name><surname>Jian</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>G</given-names></name><name><surname>Greer</surname> <given-names>D</given-names></name><name><surname>Bhandari</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Corominas</surname> <given-names>R</given-names></name><name><surname>Peoples</surname> <given-names>A</given-names></name><name><surname>Koren</surname> <given-names>A</given-names></name><name><surname>Gore</surname> <given-names>A</given-names></name><name><surname>Kang</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>GN</given-names></name><name><surname>Estabillo</surname> <given-names>J</given-names></name><name><surname>Gadomski</surname> <given-names>T</given-names></name><name><surname>Singh</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Akshoomoff</surname> <given-names>N</given-names></name><name><surname>Corsello</surname> <given-names>C</given-names></name><name><surname>McCarroll</surname> <given-names>S</given-names></name><name><surname>Iakoucheva</surname> <given-names>LM</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sebat</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Whole-genome sequencing in autism identifies hot spots for de novo germline mutation</article-title><source>Cell</source><volume>151</volume><fpage>1431</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.11.019</pub-id><pub-id pub-id-type="pmid">23260136</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondin</surname> <given-names>M</given-names></name><name><surname>Labrousse</surname> <given-names>V</given-names></name><name><surname>Hosy</surname> <given-names>E</given-names></name><name><surname>Heine</surname> <given-names>M</given-names></name><name><surname>Tessier</surname> <given-names>B</given-names></name><name><surname>Levet</surname> <given-names>F</given-names></name><name><surname>Poujol</surname> <given-names>C</given-names></name><name><surname>Blanchet</surname> <given-names>C</given-names></name><name><surname>Choquet</surname> <given-names>D</given-names></name><name><surname>Thoumine</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neurexin-neuroligin adhesions capture surface-diffusing AMPA receptors through PSD-95 scaffolds</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>13500</fpage><lpage>13515</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6439-10.2011</pub-id><pub-id pub-id-type="pmid">21940442</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulherkar</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Narayanan</surname> <given-names>A</given-names></name><name><surname>Couvillon</surname> <given-names>AD</given-names></name><name><surname>Shine</surname> <given-names>HD</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The small GTPase RhoA is required for proper locomotor circuit assembly</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e67015</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0067015</pub-id><pub-id pub-id-type="pmid">23825607</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulherkar</surname> <given-names>S</given-names></name><name><surname>Uddin</surname> <given-names>MD</given-names></name><name><surname>Couvillon</surname> <given-names>AD</given-names></name><name><surname>Sillitoe</surname> <given-names>RV</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The small GTPases RhoA and Rac1 regulate cerebellar development by controlling cell morphogenesis, migration and foliation</article-title><source>Developmental Biology</source><volume>394</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.08.004</pub-id><pub-id pub-id-type="pmid">25128586</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulherkar</surname> <given-names>S</given-names></name><name><surname>Firozi</surname> <given-names>K</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Uddin</surname> <given-names>MD</given-names></name><name><surname>Grill</surname> <given-names>RJ</given-names></name><name><surname>Costa-Mattioli</surname> <given-names>M</given-names></name><name><surname>Robertson</surname> <given-names>C</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RhoA-ROCK inhibition reverses synaptic remodeling and motor and cognitive deficits caused by traumatic brain injury</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>10689</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-11113-3</pub-id><pub-id pub-id-type="pmid">28878396</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadif Kasri</surname> <given-names>N</given-names></name><name><surname>Van Aelst</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rho-linked genes and neurological disorders</article-title><source>Pflügers Archiv - European Journal of Physiology</source><volume>455</volume><fpage>787</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1007/s00424-007-0385-1</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Kurokawa</surname> <given-names>K</given-names></name><name><surname>Kiyokawa</surname> <given-names>E</given-names></name><name><surname>Matsuda</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Analysis of the spatiotemporal activation of rho GTPases using raichu probes</article-title><source>Methods in Enzymology</source><volume>406</volume><fpage>315</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(06)06023-X</pub-id><pub-id pub-id-type="pmid">16472667</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname> <given-names>AY</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Small GTPases rac and rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>5329</fpage><lpage>5338</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-14-05329.2000</pub-id><pub-id pub-id-type="pmid">10884317</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname> <given-names>K</given-names></name><name><surname>Shiratsuchi</surname> <given-names>T</given-names></name><name><surname>Nishimori</surname> <given-names>H</given-names></name><name><surname>Inazawa</surname> <given-names>J</given-names></name><name><surname>Yoshikawa</surname> <given-names>H</given-names></name><name><surname>Taketani</surname> <given-names>Y</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Tokino</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1</article-title><source>Cytogenetic and Genome Research</source><volume>84</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1159/000015219</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>AE</given-names></name><name><surname>Jin</surname> <given-names>C</given-names></name><name><surname>Reed</surname> <given-names>JC</given-names></name><name><surname>Tsien</surname> <given-names>RY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor</article-title><source>PNAS</source><volume>101</volume><fpage>17404</fpage><lpage>17409</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408030101</pub-id><pub-id pub-id-type="pmid">15585581</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>D</given-names></name><name><surname>Tosello-Trampont</surname> <given-names>AC</given-names></name><name><surname>Elliott</surname> <given-names>MR</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Haney</surname> <given-names>LB</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Klibanov</surname> <given-names>AL</given-names></name><name><surname>Mandell</surname> <given-names>JW</given-names></name><name><surname>Ravichandran</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module</article-title><source>Nature</source><volume>450</volume><fpage>430</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1038/nature06329</pub-id><pub-id pub-id-type="pmid">17960134</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>AR</given-names></name><name><surname>Oh</surname> <given-names>D</given-names></name><name><surname>Lim</surname> <given-names>SH</given-names></name><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Moon</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>DY</given-names></name><name><surname>Park</surname> <given-names>SG</given-names></name><name><surname>Heisterkamp</surname> <given-names>N</given-names></name><name><surname>Kim</surname> <given-names>E</given-names></name><name><surname>Myung</surname> <given-names>PK</given-names></name><name><surname>Lee</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of dendritic arborization by BCR Rac1 GTPase-activating protein, a substrate of PTPRT</article-title><source>Journal of Cell Science</source><volume>125</volume><fpage>4518</fpage><lpage>4531</lpage><pub-id pub-id-type="doi">10.1242/jcs.105502</pub-id><pub-id pub-id-type="pmid">22767509</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertz</surname> <given-names>O</given-names></name><name><surname>Hodgson</surname> <given-names>L</given-names></name><name><surname>Klemke</surname> <given-names>RL</given-names></name><name><surname>Hahn</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Spatiotemporal dynamics of RhoA activity in migrating cells</article-title><source>Nature</source><volume>440</volume><fpage>1069</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1038/nature04665</pub-id><pub-id pub-id-type="pmid">16547516</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polavaram</surname> <given-names>S</given-names></name><name><surname>Gillette</surname> <given-names>TA</given-names></name><name><surname>Parekh</surname> <given-names>R</given-names></name><name><surname>Ascoli</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Statistical analysis and data mining of digital reconstructions of dendritic morphologies</article-title><source>Frontiers in Neuroanatomy</source><volume>8</volume><elocation-id>138</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2014.00138</pub-id><pub-id pub-id-type="pmid">25538569</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quassollo</surname> <given-names>G</given-names></name><name><surname>Wojnacki</surname> <given-names>J</given-names></name><name><surname>Salas</surname> <given-names>DA</given-names></name><name><surname>Gastaldi</surname> <given-names>L</given-names></name><name><surname>Marzolo</surname> <given-names>MP</given-names></name><name><surname>Conde</surname> <given-names>C</given-names></name><name><surname>Bisbal</surname> <given-names>M</given-names></name><name><surname>Couve</surname> <given-names>A</given-names></name><name><surname>Cáceres</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A RhoA signaling pathway regulates dendritic golgi outpost formation</article-title><source>Current Biology</source><volume>25</volume><fpage>971</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.01.075</pub-id><pub-id pub-id-type="pmid">25802147</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redmond</surname> <given-names>L</given-names></name><name><surname>Ghosh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The role of notch and rho GTPase signaling in the control of dendritic development</article-title><source>Current Opinion in Neurobiology</source><volume>11</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/S0959-4388(00)00181-1</pub-id><pub-id pub-id-type="pmid">11179880</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridley</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking</article-title><source>Trends in Cell Biology</source><volume>16</volume><fpage>522</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2006.08.006</pub-id><pub-id pub-id-type="pmid">16949823</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochelle</surname> <given-names>T</given-names></name><name><surname>Daubon</surname> <given-names>T</given-names></name><name><surname>Van Troys</surname> <given-names>M</given-names></name><name><surname>Harnois</surname> <given-names>T</given-names></name><name><surname>Waterschoot</surname> <given-names>D</given-names></name><name><surname>Ampe</surname> <given-names>C</given-names></name><name><surname>Roy</surname> <given-names>L</given-names></name><name><surname>Bourmeyster</surname> <given-names>N</given-names></name><name><surname>Constantin</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title><sup><italic>p210bcr-abl</italic></sup> induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1</article-title><source>FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology</source><volume>27</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1096/fj.12-205112</pub-id><pub-id pub-id-type="pmid">23047898</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roszik</surname> <given-names>J</given-names></name><name><surname>Lisboa</surname> <given-names>D</given-names></name><name><surname>Szöllősi</surname> <given-names>J</given-names></name><name><surname>Vereb</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Evaluation of intensity-based ratiometric FRET in image cytometry-Approaches and a software solution</article-title><source>Cytometry Part A</source><volume>75A</volume><fpage>761</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.20747</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruchhoeft</surname> <given-names>ML</given-names></name><name><surname>Ohnuma</surname> <given-names>S</given-names></name><name><surname>McNeill</surname> <given-names>L</given-names></name><name><surname>Holt</surname> <given-names>CE</given-names></name><name><surname>Harris</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The neuronal architecture of xenopus retinal ganglion cells is sculpted by rho-family GTPases <italic>in</italic> vivo</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>8454</fpage><lpage>8463</lpage><pub-id pub-id-type="pmid">10493746</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sando</surname> <given-names>R</given-names></name><name><surname>Bushong</surname> <given-names>E</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Considine</surname> <given-names>C</given-names></name><name><surname>Phan</surname> <given-names>S</given-names></name><name><surname>Ju</surname> <given-names>S</given-names></name><name><surname>Uytiepo</surname> <given-names>M</given-names></name><name><surname>Ellisman</surname> <given-names>M</given-names></name><name><surname>Maximov</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Assembly of excitatory synapses in the absence of glutamatergic neurotransmission</article-title><source>Neuron</source><volume>94</volume><fpage>312</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.047</pub-id><pub-id pub-id-type="pmid">28426966</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiller</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Coupling receptor tyrosine kinases to rho GTPases--GEFs what's the link</article-title><source>Cellular Signalling</source><volume>18</volume><fpage>1834</fpage><lpage>1843</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2006.01.022</pub-id><pub-id pub-id-type="pmid">16725310</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sfakianos</surname> <given-names>MK</given-names></name><name><surname>Eisman</surname> <given-names>A</given-names></name><name><surname>Gourley</surname> <given-names>SL</given-names></name><name><surname>Bradley</surname> <given-names>WD</given-names></name><name><surname>Scheetz</surname> <given-names>AJ</given-names></name><name><surname>Settleman</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>JR</given-names></name><name><surname>Greer</surname> <given-names>CA</given-names></name><name><surname>Williamson</surname> <given-names>A</given-names></name><name><surname>Koleske</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inhibition of rho via arg and p190RhoGAP in the postnatal mouse Hippocampus regulates dendritic spine maturation, synapse and dendrite stability, and behavior</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>10982</fpage><lpage>10992</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0793-07.2007</pub-id><pub-id pub-id-type="pmid">17928439</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname> <given-names>Y</given-names></name><name><surname>Kawaguchi</surname> <given-names>SY</given-names></name><name><surname>Kosaka</surname> <given-names>K</given-names></name><name><surname>Nakayama</surname> <given-names>M</given-names></name><name><surname>Hoshino</surname> <given-names>M</given-names></name><name><surname>Nabeshima</surname> <given-names>Y</given-names></name><name><surname>Hirano</surname> <given-names>T</given-names></name><name><surname>Uemura</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Opposing roles in neurite growth control by two seven-pass transmembrane cadherins</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>963</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1038/nn1933</pub-id><pub-id pub-id-type="pmid">17618280</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiratsuchi</surname> <given-names>T</given-names></name><name><surname>Nishimori</surname> <given-names>H</given-names></name><name><surname>Ichise</surname> <given-names>H</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Tokino</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAM)</article-title><source>Cytogenetic and Genome Research</source><volume>79</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1159/000134693</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigler</surname> <given-names>A</given-names></name><name><surname>Oh</surname> <given-names>WC</given-names></name><name><surname>Imig</surname> <given-names>C</given-names></name><name><surname>Altas</surname> <given-names>B</given-names></name><name><surname>Kawabe</surname> <given-names>H</given-names></name><name><surname>Cooper</surname> <given-names>BH</given-names></name><name><surname>Kwon</surname> <given-names>HB</given-names></name><name><surname>Rhee</surname> <given-names>JS</given-names></name><name><surname>Brose</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Formation and maintenance of functional spines in the absence of presynaptic glutamate release</article-title><source>Neuron</source><volume>94</volume><fpage>304</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.029</pub-id><pub-id pub-id-type="pmid">28426965</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sin</surname> <given-names>WC</given-names></name><name><surname>Haas</surname> <given-names>K</given-names></name><name><surname>Ruthazer</surname> <given-names>ES</given-names></name><name><surname>Cline</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dendrite growth increased by visual activity requires NMDA receptor and rho GTPases</article-title><source>Nature</source><volume>419</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature00987</pub-id><pub-id pub-id-type="pmid">12368855</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolowski</surname> <given-names>JD</given-names></name><name><surname>Nobles</surname> <given-names>SL</given-names></name><name><surname>Heffron</surname> <given-names>DS</given-names></name><name><surname>Park</surname> <given-names>D</given-names></name><name><surname>Ravichandran</surname> <given-names>KS</given-names></name><name><surname>Mandell</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor</article-title><source>Brain, Behavior, and Immunity</source><volume>25</volume><fpage>915</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2010.09.021</pub-id><pub-id pub-id-type="pmid">20888903</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperow</surname> <given-names>M</given-names></name><name><surname>Berry</surname> <given-names>RB</given-names></name><name><surname>Bayazitov</surname> <given-names>IT</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Baker</surname> <given-names>SJ</given-names></name><name><surname>Zakharenko</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration</article-title><source>The Journal of Physiology</source><volume>590</volume><fpage>777</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.220236</pub-id><pub-id pub-id-type="pmid">22147265</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname> <given-names>JR</given-names></name><name><surname>Paavola</surname> <given-names>KJ</given-names></name><name><surname>Schaefer</surname> <given-names>SA</given-names></name><name><surname>Kaur</surname> <given-names>B</given-names></name><name><surname>Van Meir</surname> <given-names>EG</given-names></name><name><surname>Hall</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>22248</fpage><lpage>22256</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.489757</pub-id><pub-id pub-id-type="pmid">23782696</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stigler</surname> <given-names>KA</given-names></name><name><surname>McDonald</surname> <given-names>BC</given-names></name><name><surname>Anand</surname> <given-names>A</given-names></name><name><surname>Saykin</surname> <given-names>AJ</given-names></name><name><surname>McDougle</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural and functional magnetic resonance imaging of autism spectrum disorders</article-title><source>Brain Research</source><volume>1380</volume><fpage>146</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.076</pub-id><pub-id pub-id-type="pmid">21130750</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoica</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>PJ</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Kozma</surname> <given-names>SC</given-names></name><name><surname>Costa-Mattioli</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage</article-title><source>PNAS</source><volume>108</volume><fpage>3791</fpage><lpage>3796</lpage><pub-id pub-id-type="doi">10.1073/pnas.1014715108</pub-id><pub-id pub-id-type="pmid">21307309</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takano</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Nakamuta</surname> <given-names>S</given-names></name><name><surname>Naoki</surname> <given-names>H</given-names></name><name><surname>Ishizawa</surname> <given-names>N</given-names></name><name><surname>Namba</surname> <given-names>T</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Hamaguchi</surname> <given-names>T</given-names></name><name><surname>Yura</surname> <given-names>Y</given-names></name><name><surname>Amano</surname> <given-names>M</given-names></name><name><surname>Hahn</surname> <given-names>KM</given-names></name><name><surname>Kaibuchi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Discovery of long-range inhibitory signaling to ensure single axon formation</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00044-2</pub-id><pub-id pub-id-type="pmid">28652571</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tala</surname> <given-names>I</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Hu</surname> <given-names>T</given-names></name><name><surname>Fitzpatrick</surname> <given-names>ER</given-names></name><name><surname>Williams</surname> <given-names>DA</given-names></name><name><surname>Whitehead</surname> <given-names>IP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression</article-title><source>Leukemia</source><volume>27</volume><fpage>1080</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1038/leu.2012.351</pub-id><pub-id pub-id-type="pmid">23207522</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timpson</surname> <given-names>P</given-names></name><name><surname>McGhee</surname> <given-names>EJ</given-names></name><name><surname>Morton</surname> <given-names>JP</given-names></name><name><surname>von Kriegsheim</surname> <given-names>A</given-names></name><name><surname>Schwarz</surname> <given-names>JP</given-names></name><name><surname>Karim</surname> <given-names>SA</given-names></name><name><surname>Doyle</surname> <given-names>B</given-names></name><name><surname>Quinn</surname> <given-names>JA</given-names></name><name><surname>Carragher</surname> <given-names>NO</given-names></name><name><surname>Edward</surname> <given-names>M</given-names></name><name><surname>Olson</surname> <given-names>MF</given-names></name><name><surname>Frame</surname> <given-names>MC</given-names></name><name><surname>Brunton</surname> <given-names>VG</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name><name><surname>Anderson</surname> <given-names>KI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Spatial regulation of RhoA activity during pancreatic Cancer cell invasion driven by mutant p53</article-title><source>Cancer Research</source><volume>71</volume><fpage>747</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-2267</pub-id><pub-id pub-id-type="pmid">21266354</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolias</surname> <given-names>KF</given-names></name><name><surname>Duman</surname> <given-names>JG</given-names></name><name><surname>Um</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Control of synapse development and plasticity by rho GTPase regulatory proteins</article-title><source>Progress in Neurobiology</source><volume>94</volume><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.04.011</pub-id><pub-id pub-id-type="pmid">21530608</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripodi</surname> <given-names>M</given-names></name><name><surname>Evers</surname> <given-names>JF</given-names></name><name><surname>Mauss</surname> <given-names>A</given-names></name><name><surname>Bate</surname> <given-names>M</given-names></name><name><surname>Landgraf</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Structural homeostasis: compensatory adjustments of dendritic arbor geometry in response to variations of synaptic input</article-title><source>PLOS Biology</source><volume>6</volume><elocation-id>e260</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0060260</pub-id><pub-id pub-id-type="pmid">18959482</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsushima</surname> <given-names>H</given-names></name><name><surname>Emanuele</surname> <given-names>M</given-names></name><name><surname>Polenghi</surname> <given-names>A</given-names></name><name><surname>Esposito</surname> <given-names>A</given-names></name><name><surname>Vassalli</surname> <given-names>M</given-names></name><name><surname>Barberis</surname> <given-names>A</given-names></name><name><surname>Difato</surname> <given-names>F</given-names></name><name><surname>Chieregatti</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7781</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8781</pub-id><pub-id pub-id-type="pmid">26198811</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname> <given-names>YK</given-names></name><name><surname>Duman</surname> <given-names>JG</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Adhesion-GPCR BAI1 promotes excitatory synaptogenesis by coordinating bidirectional Trans-synaptic signaling</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>8388</fpage><lpage>8406</lpage></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Um</surname> <given-names>K</given-names></name><name><surname>Niu</surname> <given-names>S</given-names></name><name><surname>Duman</surname> <given-names>JG</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Tu</surname> <given-names>YK</given-names></name><name><surname>Schwechter</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Hiles</surname> <given-names>L</given-names></name><name><surname>Narayanan</surname> <given-names>AS</given-names></name><name><surname>Ash</surname> <given-names>RT</given-names></name><name><surname>Mulherkar</surname> <given-names>S</given-names></name><name><surname>Alpadi</surname> <given-names>K</given-names></name><name><surname>Smirnakis</surname> <given-names>SM</given-names></name><name><surname>Tolias</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dynamic control of excitatory synapse development by a Rac1 GEF/GAP regulatory complex</article-title><source>Developmental Cell</source><volume>29</volume><fpage>701</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.05.011</pub-id><pub-id pub-id-type="pmid">24960694</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urdinguio</surname> <given-names>RG</given-names></name><name><surname>Lopez-Serra</surname> <given-names>L</given-names></name><name><surname>Lopez-Nieva</surname> <given-names>P</given-names></name><name><surname>Alaminos</surname> <given-names>M</given-names></name><name><surname>Diaz-Uriarte</surname> <given-names>R</given-names></name><name><surname>Fernandez</surname> <given-names>AF</given-names></name><name><surname>Esteller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mecp2-null mice provide new neuronal targets for rett syndrome</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3669</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003669</pub-id><pub-id pub-id-type="pmid">18989361</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Goietsenoven</surname> <given-names>G</given-names></name><name><surname>Mathieu</surname> <given-names>V</given-names></name><name><surname>Lefranc</surname> <given-names>F</given-names></name><name><surname>Kornienko</surname> <given-names>A</given-names></name><name><surname>Evidente</surname> <given-names>A</given-names></name><name><surname>Kiss</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers</article-title><source>Medicinal Research Reviews</source><volume>33</volume><fpage>439</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1002/med.21253</pub-id><pub-id pub-id-type="pmid">22419031</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname> <given-names>FM</given-names></name><name><surname>Ridley</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SnapShot: rho family GTPases</article-title><source>Cell</source><volume>129</volume><elocation-id>1430.e1</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2007.06.021</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>WT</given-names></name><name><surname>Faulkner-Jones</surname> <given-names>BE</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Wong</surname> <given-names>RO</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Rapid dendritic remodeling in the developing retina: dependence on neurotransmission and reciprocal regulation by rac and rho</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>5024</fpage><lpage>5036</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-13-05024.2000</pub-id><pub-id pub-id-type="pmid">10864960</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Zhuang</surname> <given-names>X</given-names></name><name><surname>Shi</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Arhgef1 negatively regulates neurite outgrowth through activation of RhoA signaling pathways</article-title><source>FEBS Letters</source><volume>590</volume><fpage>2940</fpage><lpage>2955</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12339</pub-id><pub-id pub-id-type="pmid">27489999</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yona</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>HH</given-names></name><name><surname>Siu</surname> <given-names>WO</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name><name><surname>Stacey</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Adhesion-GPCRs: emerging roles for novel receptors</article-title><source>Trends in Biochemical Sciences</source><volume>33</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2008.07.005</pub-id><pub-id pub-id-type="pmid">18789697</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Yan</surname> <given-names>R</given-names></name><name><surname>Hua</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>Q</given-names></name><name><surname>Yao</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms</article-title><source>Brain and Behavior</source><volume>7</volume><elocation-id>e00754</elocation-id><pub-id pub-id-type="doi">10.1002/brb3.754</pub-id><pub-id pub-id-type="pmid">28828215</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D</given-names></name><name><surname>Hunter</surname> <given-names>SB</given-names></name><name><surname>Vertino</surname> <given-names>PM</given-names></name><name><surname>Van Meir</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1</article-title><source>Cancer Research</source><volume>71</volume><fpage>5859</fpage><lpage>5870</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-1157</pub-id><pub-id pub-id-type="pmid">21724586</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Swanson</surname> <given-names>AM</given-names></name><name><surname>Villalba</surname> <given-names>RM</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Matheny</surname> <given-names>S</given-names></name><name><surname>Murakami</surname> <given-names>T</given-names></name><name><surname>Stephenson</surname> <given-names>JR</given-names></name><name><surname>Daniel</surname> <given-names>S</given-names></name><name><surname>Fukata</surname> <given-names>M</given-names></name><name><surname>Hall</surname> <given-names>RA</given-names></name><name><surname>Olson</surname> <given-names>JJ</given-names></name><name><surname>Neigh</surname> <given-names>GN</given-names></name><name><surname>Smith</surname> <given-names>Y</given-names></name><name><surname>Rainnie</surname> <given-names>DG</given-names></name><name><surname>Van Meir</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>BAI1 regulates spatial learning and synaptic plasticity in the Hippocampus</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>1497</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1172/JCI74603</pub-id><pub-id pub-id-type="pmid">25751059</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zunino</surname> <given-names>G</given-names></name><name><surname>Messina</surname> <given-names>A</given-names></name><name><surname>Sgadò</surname> <given-names>P</given-names></name><name><surname>Baj</surname> <given-names>G</given-names></name><name><surname>Casarosa</surname> <given-names>S</given-names></name><name><surname>Bozzi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Brain-derived neurotrophic factor signaling is altered in the forebrain of Engrailed-2 knockout mice</article-title><source>Neuroscience</source><volume>324</volume><fpage>252</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.03.023</pub-id><pub-id pub-id-type="pmid">26987954</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.47566.060</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>West</surname><given-names>Anne E</given-names></name><role>Reviewing Editor</role><aff><institution>Duke University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;The adhesion-GPCR BAI1 shapes dendrites via contact-dependent, Bcr-mediated RhoA activation causing late growth arrest&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>This manuscript reports the mechanisms and functions of the adhesion GPCR BAI1 in dendritic arborization. Loss and gain of function studies indicate that BAI1 negatively regulates dendritic growth. The loss-of-function experiments are well controlled with LOF done with two independent shRNAs causing similar effects, rescue by re-expression of an shRNA resistant BAI1, and parallel in culture and in vivo studies. Interestingly, the time course analysis conducted following knockdown shows that BAI1 is required at a late stage (&gt;14DIV) when dendrites are expanding rather than when they first emerge. The authors then address the signaling mechanisms downstream of BAI1 that mediate restriction of dendritic arborization and provide comprehensive data implicating Rho GTPases and a coupling of BAI1 to Bcr.</p><p>The reviewers felt that the manuscript was detailed and rigorous, and that it will have a high impact in the field of RhoA dependent processes that mediate control of neuronal development. We had concerns about a few points that we felt could be fully addressed upon revision with the addition of a few pieces of new data together with textual revisions.</p><p>Essential revisions:</p><p>1) Most FRET probes are used to measure signaling dynamics on the second and minute time scales. This study uses these FRET probes to quantify RhoGTPase activity at a single timepoint each day. It's unclear if these probes provide an effective readout over this timescale, and whether they can used to quantify absolute RhoGTPase activity. The authors would strengthen their interpretation of these data if they could address the following points: Is there a way to selectively and reproducibly activate BAI1 to show a rise in Raichu-RhoA or RhoA-Flare activity over seconds or minutes timeframe? Is there an alternative method to measure Rac and Rho activity to confirm FRET probe results?</p><p>2) Some controls need to be added to the shRNA experiments. In the Discussion, the authors cite previous work showing no dendritic arbor defects in BAI1 knockout mice. They suggest this lack of phenotype may be either due to compensation by BAI2/BAI3 or relate to competitive advantages that are seen in sparse knockdown but not in full knockouts. Have the authors confirmed that their shRNAs do not affect the levels of BAI2/BAI3? Considering the differences between the knockout and the shRNA experiments, this seems like a critical piece of data to add. Reviewers also asked for quantification of BAI1 knockdown at the protein level by western either from neurons or heterologous cells overexpressing BAI1. The BAI1 shRNA reagents are essential to the study and likely will be important to others who may later request it. Finally one reviewer noted that they could not find any description of the shRNA. What is the sequence? Where is it targeting BAI1? Please clarify.</p><p>3) The authors test the hypothesis that RhoA mediates BAI1's effect on dendrite growth in vitro using hippocampal neurons from RhoA conditional mice treated with tdTomato-Cre (Figure 3—figure supplement 3). Did the authors attempt to perform this experiment in vivo? It would be highly significant, if possible, to show whether electroporating tdTomato-Cre into RhoA<sup>flox/flox</sup> mice at E18 would lead to a similar BAI1-mediated dendritic overgrowth phenotype at P21 as shown in Figure 1.</p><p>4) Do the mutations the authors make in BAI1 affect the surface localization of the protein? It looks from the Materials and methods as though the BAI1 antibody targets an intracellular domain and the GFP tag is also on the intracellular side. It should be clarified if data are already shown that address this point, or it needs to be experimentally addressed.</p><p>5) Finally, all three reviewers raised concerns about the interpretation of the dendritic avoidance observation. These concerns included whether the 2D growth of neurons used here is relevant to the mechanisms of dendritic avoidance that are usually studied in vivo, how the data fit into the rest of the literature on this important (and well-studied topic), and the fact that these data do not really answer the question of what normally activates BAI1. Because we felt the experiments needed to strengthen this section were beyond the scope of the current study we suggest instead that the authors consider removing this section.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.47566.061</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Most FRET probes are used to measure signaling dynamics on the second and minute time scales. This study uses these FRET probes to quantify RhoGTPase activity at a single timepoint each day. It's unclear if these probes provide an effective readout over this timescale, and whether they can used to quantify absolute RhoGTPase activity. The authors would strengthen their interpretation of these data if they could address the following points: Is there a way to selectively and reproducibly activate BAI1 to show a rise in Raichu-RhoA or RhoA-Flare activity over seconds or minutes timeframe? Is there an alternative method to measure Rac and Rho activity to confirm FRET probe results?</p></disp-quote><p>The reviewers are correct that FRET probes are most often used for short-term (seconds to 10s of minutes) measurements. We ourselves have used an A-GPCR-specific activation mechanism (the Stachel peptide) to show BAI1-mediated Rac1 activation over such a time course (Tu et al., 2018). However, we do not yet know the ligand(s) that promote RhoA activation via BAI1. One of the advantages of the construction of single-molecule probes like the Raichu and FLARE probes used in our manuscript is that, in principle, they are able to be calibrated and to provide reproducible, quantitative readouts over long periods of time. This means that if the imaging conditions (e.g., optics, lasers, detectors, temperature, media) do not change, the readout from the probe should be reproducible for any condition measured by and within the range of the probe. (That the Rho-GTPase activation probes have not been calibrated has more to do with creating accurate calibration conditions than with the probes themselves. Calcium probes created on the same backbone have been successfully calibrated thanks to the availability of calcium buffers, e.g. Palmer et al., 2004.) Moreover, Raichu-type probes have been used to record measurements for longer periods ranging from 10 hours to at least eight days (Kim et al., 2014; Konopa et al., 2016; Timpson et al., 2011).</p><p>Having said this, we did want to show that our measurements were stable over longer time frames than those more commonly used and have included these measurements in Figure 3—figure supplement 1. We show 24-hour stability for Raichu-RhoA probes mutated to give specific outcomes, for normal Raichu-RhoA in cells expressing RhoA GAPs and GEFs, and for normal Raichu-Rac1 in cells expressing Rac1 GAPs and GEFs. We also show that within the experiments shown in Figure 3D-I, short-term measurements are stable. Together, these data indicate that the FRET probes used reproducibly report expected results over at least 24 hours in Cos-7 cells. We were not able to perform these measurements in neurons because the dynamic nature of RhoA and Rac1 signaling during neuronal development and function makes it impossible to ‘clamp’ Rac1 and RhoA signaling states, even when regulatory proteins are overexpressed.</p><disp-quote content-type="editor-comment"><p>2) Some controls need to be added to the shRNA experiments. In the Discussion, the authors cite previous work showing no dendritic arbor defects in BAI1 knockout mice. They suggest this lack of phenotype may be either due to compensation by BAI2/BAI3 or relate to competitive advantages that are seen in sparse knockdown but not in full knockouts. Have the authors confirmed that their shRNAs do not affect the levels of BAI2/BAI3? Considering the differences between the knockout and the shRNA experiments, this seems like a critical piece of data to add. Reviewers also asked for quantification of BAI1 knockdown at the protein level by western either from neurons or heterologous cells overexpressing BAI1. The BAI1 shRNA reagents are essential to the study and likely will be important to others who may later request it. Finally one reviewer noted that they could not find any description of the shRNA. What is the sequence? Where is it targeting BAI1? Please clarify.</p></disp-quote><p>The reviewers are correct that these reagents are essential to this study, and we welcome the opportunity to address the points that they made. First, we have included the sequences of the shRNAs and indicated where they match to the rat BAI1 mRNA sequence in the Materials and methods section. Second, we have added new Figure 1—figure supplement 1 with additional original data to address shRNA function and possible compensation. These include: a cartoon depiction of the sites for both shRNAs within the rat BAI1 mRNA (panel a); RT-PCR showing BAI1, but neither BAI2 nor BAI3, knock down at the mRNA level in hippocampal neurons (panel b); Western blots showing BAI1, but neither BAI2 nor BAI3, knock down at the protein level in hippocampal neurons (panel c); quantification of the Western data in panel c (panel d); and serial dilution of control and BAI1 Kd samples showing linearity and loading controls in both pSuper- and shRNA-expressing neurons (panel e). We did these experiments using calcium phosphate transfection under conditions that affect 40-50% of hippocampal neurons. While other methods (e.g., LipofectAmine, virus) lead to potentially greater transfection levels, calcium phosphate better preserves the health of the neurons and is more similar to the conditions under which most of the experiments in this paper were performed. We also note that the primary focus of the BAI1 KO paper is spines and synapses, and there is no rigorous analysis of dendritic arbors in this paper (Zhu et al., 2015). It is therefore possible that we proposed a resolution of a problem that does not exist.</p><disp-quote content-type="editor-comment"><p>3) The authors test the hypothesis that RhoA mediates BAI1's effect on dendrite growth in vitro using hippocampal neurons from RhoA conditional mice treated with tdTomato-Cre (Figure 3—figure supplement 3). Did the authors attempt to perform this experiment in vivo? It would be highly significant, if possible, to show whether electroporating tdTomato-Cre into RhoA<sup>flox/flox</sup> mice at E18 would lead to a similar BAI1-mediated dendritic overgrowth phenotype at P21 as shown in Figure 1.</p></disp-quote><p>We agree that this would be an interesting experiment that would extend the similarity of BAI1 and RhoA loss-of-function phenotypes from culture to an in vivo model. Under the best of circumstances, it would have been difficult to complete this experiment within the editors’ recommended time frame for revisions, but our colony of RhoA<sup>flox/flox</sup> mice was low and staffing changes further complicated completion. In order to maintain a reasonable timeline, we have not performed this experiment. We have included additional references to the Discussion to paint a clearer picture of RhoA function in dendrite development. We hope that this will address at least some of the reviewers’ concerns.</p><p>We want to emphasize two points with regard to this experiment: (1) we are not opposed in principle to doing this experiment and could (and would) complete it if given more time. If the reviewers and editors decide that this experiment is mandatory for publication of this study in <italic>eLife</italic>, then we respectfully ask for a substantial extension in order to complete it. (2) We already present a large amount of data linking BAI1 to RhoA in dendrite growth arrest in this paper. In addition to the similarity between BAI1 Kd and RhoA KO phenotypes, we show that: (i) loss of BAI1 from hippocampal neurons leads to both dendrite overgrowth and lowered RhoA activation in two completely independent experiments using two different probes of RhoA activity; (ii) that BAI1 mutants that rescue dendrite overgrowth also rescue lowered RhoA activation, but that one mutant that fails to rescue dendrite overgrowth also fails to rescue lowered RhoA activation; (iii) BAI1 associates with the RhoA-GEF Bcr and this association strengthens at the time of dendritic growth arrest; (iv) Bcr is also required for normal dendritic growth arrest; (v) BAI1 and Bcr co-expression increases Bcr’s RhoA-GEF activity; (vi) Bcr’s RhoA-GEF activity is required for dendritic growth arrest; and (vii) use of pharmacological agents to activate RhoA or inhibit RhoA-dependent kinases reversed the effects of BAI1 gain- and loss-of-function, respectively.</p><disp-quote content-type="editor-comment"><p>4) Do the mutations the authors make in BAI1 affect the surface localization of the protein? It looks from the Materials and methods as though the BAI1 antibody targets an intracellular domain and the GFP tag is also on the intracellular side. It should be clarified if data are already shown that address this point, or it needs to be experimentally addressed.</p></disp-quote><p>The reviewers’ point is well taken. The mutants are not GFP-tagged, but we do have antibodies against both N-terminal (extracellular) and C-terminal (intracellular) epitopes of BAI1. This allowed us to demonstrate that wild-type BAI1, as well as the ∆TEV, RKR, ∆GPCR, and ∆PRR mutants localize to the surface of Cos-7 cells expressing them. The BAI1 ∆N-term. mutant does not contain the N-terminal epitope and so was not amenable to these experiments. However, in light of the inability of ∆N-term. to rescue the spine and synaptic phenotypes arising from BAI1 loss, we had already used a N-terminally flag-tagged version of this mutant to demonstrate its surface localization (Tu et al., 2018). In our revision, we have added these data as Figure 5—figure supplement 2, discussed the surface localization of BAI1-∆N-term. in the legend to these data, included our surface labeling protocol, and made textual changes to incorporate these data into the manuscript.</p><disp-quote content-type="editor-comment"><p>5) Finally, all three reviewers raised concerns about the interpretation of the dendritic avoidance observation. These concerns included whether the 2D growth of neurons used here is relevant to the mechanisms of dendritic avoidance that are usually studied in vivo, how the data fit into the rest of the literature on this important (and well-studied topic), and the fact that these data do not really answer the question of what normally activates BAI1. Because we felt the experiments needed to strengthen this section were beyond the scope of the current study we suggest instead that the authors consider removing this section.</p></disp-quote><p>We understand the reviewers’ concerns and have removed this section and all references to it in other parts of the paper, including the title, summary, Discussion, Materials and methods, figure legends, and supplementary data.</p></body></sub-article></article>